UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.20549

FORM 10-Q

(Mark one)

[X]QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended NovemberSeptember 30, 20172021

[  ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-17284

AIXIN LIFE INTERNATIONAL, INC.

MERCARI COMMUNICATIONS GROUP, LTD.

(Exact name of registrant as specified in its charter)

Colorado84-1085935

(State or other jurisdiction of

of incorporation or organization)

(IRS Employer

Identification No.)

Hongxing International Business Building 2, 14th14th FL, No. 69 Qingyun South Ave., Jinjiang District

Chengdu City, Sichuan Province,China

(Address of principal executive offices)

1120 Avenue of the Americas, 4th floor, New York, NY 1003686-313-6732526

(Former Address of principal executive offices)

86-400-6260600

(Issuer’s telephone number)

Securities Registered Pursuant to Section 12(g) of the Act:

Title of Each ClassTrading Symbol(s)Name of each Exchange on which Registered
Common Stock, $0.001 Par ValueAIXNOTCQX Venture

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [X] No [  ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer[  ]Accelerated filer[  ]
Non-accelerated filer[  ](Do not check if a smaller reporting company)Smaller reporting company[X]
Emerging growth company[X]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) [  ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [X] No [  ]

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practical date: As of January 5, 2018,November 12, 2021, there were outstanding 317,988,089 49,999,891shares of the registrant’s common stock.

 

 

 

AIXIN LIFE INTERNATIONAL, INC.

MERCARI COMMUNICATIONS GROUP, LTD.

FORM 10-Q

NovemberSeptember 30, 20172021

INDEX

INDEX

Page
Cautionary StatementSpecial Note Regarding Forward-looking InformationForward Looking Statements3
Part I – Financial Information4
Item 1.CondensedConsolidated Financial Statements4
CondensedConsolidated Balance Sheets4
CondensedConsolidated Statements of OperationsIncome and Comprehensive Income5
CondensedConsolidated Statements of Stockholders’ Equity6
Consolidated Statements of Cash Flows67
Notes to CondensedConsolidated Financial Statements78
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations1327
Item 3.Quantitative And Qualitative Disclosures About Market Risk15
Item 4.Controls and Procedures1535
Part II – Other Information36
Item 1.Legal Proceedings1636
Item 1A.Risk Factors1636
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds1636
Item 3.Defaults Upon Senior Securities1636
Item 4.5.Mine Safety DisclosuresOther Information1636
Item 5.6.Other InformationExhibits1636
Item 6.ExhibitsSignatures17
Signatures1837

2
 2

SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
INFORMATION

This Quarterly Reportreport contains forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “would” and similar expressions intended to identify forward-looking statements. Forward-looking statements reflect our current views with respect to future events and are based on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 about Mercari Communications Group, Ltd. (the “Company,” “Mercari,” “we,” “us,”assumptions and “our”) that are subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on forward-looking statements. Forward-looking statements include, information concerning future financial performance, business strategy, projected plans and objectives. Statements preceded by, followed by or that otherwise include the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “may increase,” “may fluctuate” and similar expressions of future or conditional verbs such as “will,” “should,” “would,” and “could” are generally forward-lookingamong other things, statements relating to:

our goals and strategies;
our future business development, financial condition and results of operations;
our expectations regarding demand for, and market acceptance of, our products;
our expectations regarding keeping and strengthening our relationships with merchants, manufacturers and end-users; and
general economic and business conditions in nature and not historical facts. Actual results may differ materially from those projected, implied, anticipated or expected in the forward-looking statements. Readers of this Quarterly Report should not rely solely on the regions where we provide our services.

Also, forward-looking statements represent our estimates and should consider all uncertainties and risks throughout this report. The statements are representativeassumptions only as of the date they are made. The Company undertakesof this report. You should read this report and the documents that we reference and filed as exhibits to the report completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update any forward-looking statement.

These forward-looking statements implicitly and explicitly, includepublicly, or to update the assumptions underlying the statements and other information with respect to the Company’s beliefs, plans, objectives, goals, expectations, anticipations, estimates, financial condition, results of operations, future performance and business, including management’s expectations and estimates with respect to revenues, expenses, return on equity, return on assets, asset quality and other financial data.

Although the Company believes the expectations reflected in the forward-looking statements are reasonable, these statements involve risks and uncertainties that are subject to change based on various important factors, some of which are beyond the control of the Company. The following factors, among others, could cause the Company’s results or financial performance to differ materially from its goals, plans, objectives, intentions, expectations and other forward-looking statements:

general economic and industry conditions;
limited resources and need for additional financing;
competition for suitable private companies with which to merge;
no definitive agreements or business opportunities identified;
substantial dilution to current shareholders if a merger occurs; and
our stock is thinly traded with limited liquidity.

All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update this Quarterly Report on Form 10-Q to reflect events or circumstances after the date hereof. New factors emerge from time to time, and it is not possible for us to predict which factors, if any, will arise. In addition, the Company cannot assess the impact of each factor on the Company’s business or the extent to which any factor, or combination of factors, may causereasons actual results tocould differ materially from those containedanticipated in any forward-looking statements.statements, even if new information becomes available in the future.

Use of Certain Defined Terms

Except where the context otherwise requires and for the purposes of this report only:

the “Company,” “we,” “us,” and “our” refer to AiXin Life International, Inc. (“AiXin”) and its subsidiaries.

“Exchange Act” refers to the Securities Exchange Act of 1934, as amended;

“Hong Kong” refers to the Hong Kong Special Administrative Region of the People’s Republic of China;

“PRC,” “China,” and “Chinese,” refer to the People’s Republic of China (excluding Hong Kong and Taiwan);

“Renminbi” and “RMB” refer to the legal currency of China;

“Securities Act” refers to the Securities Act of 1933, as amended; and

“US dollars,” “dollars” and “$” refer to the legal currency of the United States.

3
 3

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

MERCARI COMMUNICATIONS GROUP, LTD

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED BALANCE SHEETS

  November 30, 2017 (Unaudited)  May 31, 2017 (Audited) 
       
ASSETS        
         
CURRENT ASSETS        
Cash $-  $- 
         
Total assets     $- 
         
LIABILITIES AND STOCKHOLDERS’ DEFICIT        
         
CURRENT LIABILITIES        
Accounts payable and accrued liabilities $5,528  $38,228 
Due to third party  5,500   - 
Due to related parties  248,265   166,677 
         
Total liabilities  259,292   204,905 
         
STOCKHOLDERS’ DEFICIT        
Common stock, par value $0.0001 per share, 950,000,000 shares authorized; 45,411,400 shares issued and outstanding  454   454 
Additional paid in capital  158,722   158,722 
Accumulated deficit  (418,468)  (364,081)
         
Total stockholders’ deficit  (259,292)  (204,905)
         
TOTAL LIABILITIES AND DEFICIT $-  $- 
  September 30,  December 31 
  2021  2020 
   (Unaudited)     
Assets        
Current assets        
Cash and cash equivalents $3,297,835  $7,676,689 
Accounts receivable, net  32,558   - 
Other receivables and prepaid expenses  214,075   32,323 
Advances to suppliers  279,859   155,686 
Inventories  319,605   45,535 
Advances to related parties  15,507   15,739 
Total current assets  4,159,439   7,925,972 
Property and equipment, net  359,412   67,817 
Intangible asset, net  2,569   - 
Security deposit  93,119   - 
Operating lease right-of-use assets  2,050,023   100,029 
Total assets $6,664,562  $8,093,818 
         
Liabilities and stockholders’ equity        
Current liabilities        
Accounts payable $428,402  $39,122 
Unearned revenue  306,095   - 
Taxes payable  334,517   283,495 
Accrued liabilities and other payables  844,791   514,239 
Loan from third parties  463,229   - 
Operating lease liabilities - current  844,093   70,780 
Advance from related parties  118,008   264,850 
Total current liabilities  3,339,135   1,172,486 
Operating lease liabilities - non-current  1,205,932   29,250 
Total liabilities  4,545,067   1,201,736 
         
Stockholders’ equity        
Undesignated preferred stock, $0.001 par value, 20,000,000 shares authorized, NaN issued and outstanding  -   - 
Common stock, par value $0.00001 per share, 500,000,000 shares authorized; 49,999,891 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively  500   500 
Additional paid in capital  9,585,799   11,115,765 
Statutory reserve  151,988   151,988 
Accumulated deficit  (8,291,094)  (4,964,711)
Accumulated other comprehensive income  672,302   588,540 
Total stockholders’ equity  2,119,495   6,892,082 
         
Total liabilities and stockholders’ equity $6,664,562  $8,093,818 

The accompanying notes are an integral part of these financial statements.statements

4
 4

MERCARI COMMUNICATIONS GROUP, LTDAIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF OPERATIONSINCOME AND COMPREHENSIVE INCOME

(UNAUDITED)

  For The Six Months Ended November 30,  For The Three Months Ended November 30, 
  2017  2016  2017  2016 
             
Revenue $-  $-  $-  $- 
                 
Expenses                
General and administrative  54,387   20,869   20,500   11,949 
                 
Net loss $(54,387) $(20,869) $(20,500) $(11,949)
                 
Basic and diluted loss per share $(0.001) $(0.0005)  (0.000)  (0.0003)
                 
Weighted average shares  45,411,400   45,411,400  $45,411,400  $45,411,400 
  2021  2020  2021  2020 
  Three Months Ended
September 30,
  Nine Months Ended
September 30,
 
  2021  2020  2021  2020 
             
Revenues:                
Products $204,593  $54,918  $457,838  $170,333 
Advertising  445,215   673,978   1,742,896   1,603,806 
Room revenues  68,559   -   68,559   - 
Food and beverage revenues  71,015   -   71,015   - 
Others  23,528   -   23,528   - 
Total revenue, net  812,910   728,896   2,363,836   1,774,139 
                 
Operating costs and expenses:                
Cost of goods sold  130,938   20,478   291,618   67,379 
Hotel operating costs  320,305   -   320,305   - 
Selling  156,587   51,409   250,468   182,293 
General and administrative  187,820   244,772   607,741   580,470 
Provision for bad debts  17,884   75   17,884   13,451 
Stock-based compensation  92,885   92,885   278,655   278,655 
Total operating costs and expenses  906,419   409,619   1,766,671   1,122,248 
                 
Income (loss) from operations  (93,509)  319,277   597,165   651,891 
                 
Non-operating income (expenses)                
Interest income  599   297,895   3,088   529,551 
Other income  22,067   25,741   22,228   25,783 
Other expense  (1,167)  (263)  (8,052)  (449)
Total non-operating income, net  21,499   323,373   17,264   554,885 
                 
Income (loss) before income tax  (72,010)  642,650   614,429   1,206,776 
                 
Income tax expense  74,094   2,319   292,146   2,319 
                 
Net income (loss)  (146,104)  640,331   322,283   1,204,457 
                 
Other comprehensive items                
Foreign currency translation gain  6,638   260,711   83,762   179,390 
                 
Comprehensive income (loss) $(139,466) $901,042  $406,045  $1,383,847 
                 
Income per share - basic and diluted $(0.003) $0.013  $0.006  $0.017 
                 
Weighted average shares outstanding  49,999,891   49,999,901   49,999,891   70,850,620 

The accompanying notes are an integral part of these financial statements.statements

5
 5

MERCARI COMMUNICATIONS GROUP, LTDAIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWSSTOCKHOLDERS’ EQUITY

(UNAUDITED)

  FOR THE SIX MONTHS ENDED NOVEMBER 30, 
  2017  2016 
       
CASH FLOWS FROM OPERATING ACTIVITIES        
Net loss $(54,387) $(20,869)
Change in operating assets and liabilities        
Accounts payable and accrued liabilities  (32,701)  (2,368)
         
Net cash used in operating activities  (87,088)  (23,237)
         
CASH FLOWS FROM FINANCING ACTIVITIES        
Due to third party  5,500   - 
Due to related parties  81,588   22,100 
         
Net cash provided by financing activities  87,088   22,100 
         
NET INCREASE IN CASH AND CASH EQUIVALENTS  -   (1,137)
         
CASH AT THE BEGINNING OF PERIOD  -   1,765 
         
CASH AT THE END OF PERIOD $-  $628 
  Shares  Amount  capital  reserves  deficit  income  Total 
  

Common Stock

  

Additional
paid in

  

Statutory

  

Accumulated

  

Accumulated
other
comprehensive

    
  Shares  Amount  capital  reserves  deficit  income  Total 
Balance at December 31, 2020  49,999,891  $500  $11,115,765  $151,988  $(4,964,711) $588,540   6,892,082 
Cancellation of shares                            
Cancellation of shares, shares                            
Stock-based compensation  -   -   92,885   -   -   -   92,885 
Net income  -   -   -   -   221,702   -   221,702 
Foreign currency translation  -   -   -   -   -   (32,609)  (32,609)
Balance at March 31, 2021  49,999,891   500   11,208,650   151,988   (4,743,009)  555,931   7,174,060 
Stock-based compensation  -   -   92,885   -   -   -   92,885 
Net income  -   -   -   -   246,685   -   246,685 
Foreign currency translation  -   -   -   -   -   109,733   109,733 
Balance at June 30, 2021  49,999,891   500   11,301,535   151,988   (4,496,324)  665,664   7,623,363 
Acquisition of subsidiaries  -   -   (4,257,275)  -   (3,648,666)  -   (7,905,941)
Debt forgiven by major shareholder          2,448,654               2,448,654 
Stock-based compensation  -   -   92,885   -   -   -   92,885 
Net income  -   -   -   -   (146,104)  -   (146,104)
Foreign currency translation  -   -   -   -       6,638   6,638 
Balance at September 30, 2021  49,999,891  $500  $9,585,799  $151,988  $(8,291,094) $672,302  $2,119,495 
                             
                             
Balance at December 31, 2019  85,049,576  $850  $10,743,875  $11,721  $(5,841,955) $151,481  $5,065,972 
Stock-based compensation  -   -   92,885   -   -   -   92,885 
Net income  -   -   -   -   248,217   -   248,217 
Foreign currency translation  -   -       -   -   (94,382)  (94,382)
Balance at March 31, 2020  85,049,576   850   10,836,760   11,721   (5,593,738)  57,099   5,312,692 
Cancellation of shares  (35,049,685)  (350)  350   -   -   -   - 
Stock-based compensation  -   -   92,885   -   -   -   92,885 
Net income  -   -   -   -   315,909   -   315,909 
Foreign currency translation  -   -   -   -   -   13,061   13,061 
Balance at June 30, 2020  49,999,891   500   10,929,995   11,721   (5,277,829)  70,160   5,734,547 
Beginning balance  49,999,891   500   10,929,995   11,721   (5,277,829)  70,160   5,734,547 
Stock-based compensation  -   -   92,885   -   -   -   92,885 
Net income  -   -   -   -   640,331   -   640,331 
Foreign currency translation  -   -   -   -   -   260,711   260,711 
Balance at September 30, 2020  49,999,891  $500  $11,022,880  $11,721  $(4,637,498) $330,871  $6,728,474 
Ending balance  49,999,891  $500  $11,022,880  $11,721  $(4,637,498) $330,871  $6,728,474 

The accompanying notes are an integral part of these financial statements.statements

6
 

AIXIN LIFE INTERNATIONAL, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

  2021  2020 
  For the Nine Months Ended
September 30
 
  2021  2020 
       
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net income $322,283  $1,204,457 
Adjustments required to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization  21,910   34,572 
Provision for bad debts  17,883   13,451 
Stock-based compensation  278,655   278,655 
Changes in net assets and liabilities:        
Accounts receivable  (12,806)  - 
Accounts receivable - related party  13,618   - 
Other receivables and prepaid expenses  22,975   17,327 
Advances to suppliers  (116,795)  63,235 
Inventories  (18,728)  (31,830)
Accounts payable  (748)  (5)
Unearned revenue  13,136   1,074 
Taxes payable  46,672   (24,966)
Accrued liabilities and other payables  (41,986)  (99,549)
Net cash provided by operating activities  546,069   1,456,421 
         
CASH FLOWS FROM INVESTING ACTIVITIES:        
Purchase of property and equipment  -   (2,145)
Cash acquired at acquisition of subsidiaries  87,448   - 
Return of (payment) for acquisition  (4,497,972)  4,035,615 
Net cash (used in) provided by investing activities  (4,410,524)  4,033,470 
         
CASH FLOWS FROM FINANCING ACTIVITIES:        
Change in advance from related parties  (592,814)  2,227,904 
Net cash (used in) provided by financing activities  (592,814)  2,227,904 
         
EFFECT OF EXCHANGE RATE CHANGE ON CASH  78,415   231,172 
         
NET (DECREASE) INCREASE IN CASH  (4,378,854)  7,948,967 
         
CASH, BEGINNING OF PERIOD  7,676,689   9,833 
         
CASH, END OF PERIOD $3,297,835  $7,958,800 
         
Supplemental Cash flow data:        
Income tax paid $282,319  $2,319 
Interest paid $-  $- 

The accompanying notes are an integral part of these financial statements

67
 

AIXIN LIFE INTERNATIONAL, INC.

MERCARI COMMUNICATIONS GROUP, LTD.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOVEMBER 30, 2017 (UNAUDITED) AND MAY 31, 2017

NOTE 1 - 1. ORGANIZATION AND SUMMARYDESCRIPTION OF SIGNIFICANT ACCOUNTING POLICIESBUSINESS

Organization

Mercari Communications Group, Ltd.Aixin Life International, Inc. (the “Company” or “Aixin Life” or “we”) was incorporated under the laws of the State of Coloradoon December 30, 1987. From 1988 until 1990,1987under the Company provided educational products, counseling, seminar programs, and publications such as newsletters to adults aged 30 to 50. The Company financed its business with private offerings of securities, shareholder loans, and with an underwritten initial public offering of securities registered with the Securities and Exchange Commissionname Mercari Communications Group, Ltd (“SEC”Mercari”). The Company’sMercari’s business failed in 1990. The Company ceased all operationsMercari conducted no operating activities from June 1, 1990 to August 31, 2001 and was dormant.

During the periodeach year since Mercari was reactivated until 2017, the Company had no revenue and had losses approximately equal to the expenditures required to reactivate and comply with filing and reporting obligations. Expenditures were paid by Mercari from capital contributions and loans made by Mercari’s principal stockholders and entities controlled by Mercari’s directors.

On January 20, 2017, Mercari’s principal stockholders, Algodon, sold 10,955,500 shares of the Company’s common stock, 96.5% of the Company’s outstanding shares, to China Concentric, for $260,000, and assigned its right to the repayment of $150,087 of non-interest bearing advances to the Company for working capital, pursuant to a Stock Purchase Agreement dated December 20, 2016, as amended. Prior to entering into the Stock Purchase Agreement with Algodon, neither China Concentric nor any of its affiliates had any relationship to the Company, Algodon or any of their respective affiliates.

On February 2, 2017, Mr. Quanzhong Lin purchased 7,380,352 shares of the Company’s common stock, 65.0% of its outstanding shares from China Concentric for $300,000, pursuant to a Stock Purchase Agreement dated December 21, 2016, which resulted in a change in control of our company.

On December 12, 2017, the Company issued 56,838,151 shares of common stock to Mr. Lin, the sole stockholder of AiXin (BVI) International Group Co., Ltd. a British Virgin Islands corporation (“AiXin BVI”), for his shares of AiXin BVI, pursuant to a Share Exchange Agreement.

As a result of the Share Exchange, AiXin BVI became the Company’s wholly-owned subsidiary, and the Company now owns all of the outstanding shares of HK AiXin International Group Co., Limited, a Hong Kong limited company (“AiXin HK”), which in turn owns all of the outstanding shares of Chengdu AiXinZhonghong Biological Technology Co., Ltd., a Chinese limited company (“AiXinZhonghong”), which markets and sells premium-quality nutritional products in China.

AiXin BVI was dormant, it did not file required reports withincorporated on September 21, 2017 as a holding company and AiXin HK was established in Hong Kong on February 25, 2016 as an intermediate holding company. AiXinZhonghong was established in the SEC underPeople’s Republic of China (“PRC”) on March 4, 2013, and on May 27, 2017, the Securities Exchange Actlocal government of 1934,the PRC issued a certificate of approval regarding the foreign ownership of AiXinZhonghong by AiXin HK. Neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017.

8

For accounting purposes, the acquisition was accounted for as amended (“Exchange Act”). On August 3, 2004, the shareholdersa reverse acquisition and treated as a recapitalization of the Company approvedeffected by a planshare exchange, with AiXin BVI as the accounting acquirer. Since neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017, the historical consolidated financial statements of quasi-reorganizationAiXinZhonghong are now the historical consolidated financial statements of the Company. The assets and liabilities of AiXinZhonghong were brought forward at their book value and no goodwill was recognized.

Effective February 1, 2018, pursuant to Articles of Amendment to the Company’s Articles of Incorporation filed with the Secretary of State of Colorado, the Company changed its name to AiXin Life International., Inc (“Aixin Life”).

The Company, through its indirectly owned AiXinZhonghong subsidiary, mainly develops and distributes consumer products by offering a line of nutritional products. The Company sells the products through exhibition events, conferences, and person-to-person marketing. Beginning in 2019, the Company began to provide advertising services to clients who engaged the Company to help distribute their products. The Company’s business mainly focuses on a proactive approach to its customers such as hosting events for clients, which calledit believes is ideally suited to marketing its products because sales of nutrition products are strengthened by ongoing personal contact and support, coaching and education of its clients, as to the benefits of a healthy and active lifestyle.

On May 25, 2021, AiXin HK entered into an Equity Transfer Agreement with Chengdu Aixin Shangyan Hotel Management Co., Ltd (“Aixin Shangyan Hotel”), and its two shareholders Quanzhong Lin and Yirong Shen (“Transferor”). Pursuant to the agreement (the “Hotel Purchase Agreement”), Aixin Life agreed to purchase 100% ownership of Aixin Shangyan Hotel from Mr. Lin and Ms. Shen. Eighty percent of the equity of Aixin Shangyan Hotel is owned by Mr. Lin, and the remaining balance is owned by Ms. Shen. Under the terms of the Hotel Purchase Agreement, Aixin Life agreed to purchase all of the outstanding equity of Aixin Shangyan Hotel for a restatementpurchase price of accountsRMB 7,598,887, or approximately $1.16 million (the “Transfer Price”). The Transfer Price will be reduced by an amount equal to eliminateany amounts paid or distributed by Aixin Shangyan Hotel to the accumulated deficit and related capital accounts on the Company’s balance sheet. The quasi-reorganization was effective March 1, 2004. Since March 1, 2004, the Company is in the development stage, and has not commenced planned principal operations. The Company has no products or services as of November 30, 2017.

Going Concern

The accompanying financial statements were prepared on the basis of accounting principles applicable to a “going concern”, which assume that the Company will continue in operation for at least one yearTransferor after December 31, 2020 and will be ableincreased by an amount equal to realizeany amounts contributed to Aixin Shangyan Hotel by the Transferor after December 31, 2020. The acquisition was completed in July 2021.

On June 2, 2021, AiXin HK entered into an Equity Transfer Agreement with Chengdu Aixintang Pharmacy Co., Ltd. and certain affiliated entities, each of which operates a pharmacy (together, “Aixintang Pharmacies”) and its assetsthree shareholders, Quanzhong Lin, Ting Li and discharge its liabilitiesXiao Ling Li (“Transferor”). Mr. Lin owns in the normal courseexcess of operations.

Several conditions and events cast doubt about the Company’s ability to continue as a “going concern.” The Company has incurred net losses of $54,387 for the six months ended November 30, 2017, has no revenues and requires additional financing in order to finance its business activities on an ongoing basis. The Company’s future capital requirements will depend on numerous factors including, but not limited to, continued progress in finding a merger candidate and the pursuit of business opportunities. In the interim, shareholders95% of the Company have been contributing capitaloutstanding equity the Aixintang Pharmacies. The remaining equity interest is owned by Ting Li and Xiao Ling Li.Pursuant to the Companyagreement (the “Pharmacies Purchase Agreement”), AiXin HK agreed to meet its ordinarypurchase all of the outstanding equity of Aixintang Pharmacies for an aggregate purchase price of RMB 34,635,845, or approximately US$5.31 million (the “Transfer Price”). The Transfer Price will be reduced by an amount equal to any amounts paid or distributed by any of the Aixintang Pharmacies to the Transferor after December 31, 2020 and normal operating expenses. Management believes that actions presently being takenincreased by an amount contributed to reviseany of the Company’s operating and financial requirements provide it withAixintang Pharmacies by the opportunity to continue as a “going concern”.Transferor after such date. The acquisition was completed in September 2021.

These2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying consolidated financial statements do not reflect adjustments that would be necessary if the Company were unable to continue as a “going concern”. While management believes the actions already taken or planned, will mitigate the conditions and events which raise doubt about the validity of the “going concern” assumption used in preparing these financial statements, there can be no assurance these actions will be successful. If the Company were unable to continue as a “going concern,” then substantial adjustments would be necessary to the carrying values of assets, the reported amounts of its liabilities, the reported revenues and expenses, and the balance sheet classifications used.

Basis of Presentation

The financial statements wereare prepared in conformity with accounting principles generally accepted in the United States of AmericaU.S. Generally Accepted Accounting Principles (“US GAAP”). The functional currency of AiXinZhonghong, Aixin Shangyan Hotel and pursuant toAixintang Pharmacies is Chinese Renminbi (‘‘RMB’’). The accompanying consolidated financial statements are translated from RMB and presented in U.S. dollars (“USD”).

The consolidated financial statements include the accounts of the Company and its current wholly owned subsidiaries, AiXin HK, AiXinZhonghong, Aixin Shangyan Hotel and Aixintang Pharmacies. Intercompany transactions and accounts were eliminated in consolidation.

9

Unaudited Interim Financial Information

These unaudited interim financial statements have been prepared in accordance with GAAP for interim financial reporting and the rules and regulations of the SECSecurities and Exchange Commission that permit reduced disclosure for annualinterim periods. Therefore, certain information and footnote disclosures normally included in financial statements.

Cash and Cash Equivalents

For purposesstatements prepared in accordance with GAAP have been condensed or omitted. In the opinion of management, all adjustments of a normal recurring nature necessary for a fair presentation of the statementfinancial position, results of operations and cash flows for the periods presented have been made. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the year ending December 31, 2021.

The balance sheets and certain comparative information as of December 31, 2020 are derived from the audited financial statements and related notes for the year ended December 31, 2020, included in the Company’s 2020 Annual Report on Form 10-K. These unaudited interim financial statements should be read in conjunction with the annual consolidated financial statements and the accompanying notes contained in our Annual Report on Form 10-K for the year ended December 31, 2020.

Reclassification

Certain prior period amounts have been reclassified to conform to the current period presentation and had no effect on previously reported consolidated net income (loss) or accumulated deficit.

Covid – 19

On March 11, 2020, the World Health Organization announced that infections caused by the corona virus disease of 2019 (“COVID-19”) had become pandemic. The Government of China has adopted various regulations and orders, including mandatory quarantines, limits on the number of people that may gather in one location, closing non-essential businesses and travel bans to limit the spread of the disease. Many of these measures have been relaxed due to the decrease in the prevalence of Covid-19 in China. To date, the ongoing operations of the Company considers all highly liquid debt instruments purchased with a maturityhave not been materially adversely effected by the measures taken to limit the spread of three months or lessthe disease in China.

Financial impacts related to be cash equivalentsCOVID-19, including the Company’s actions and costs incurred in response to the extentpandemic, were not material to the funds areCompany’s financial position, results of operations or cash flows for the period ended September 30, 2021. The Company has implemented procedures to promote employee and customer safety. These measures will not being held for investment purposes.significantly increase its operating costs. However, the Company cannot predict with certainty what measures may be taken by its suppliers and customers and the impact these measures may have on its 2021 financial position, results of operations or cash flows.

7

Use of Estimates

The preparation ofIn preparing consolidated financial statements in conformity with US GAAP, required management to makemakes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosuredisclosures of contingent assets and liabilities at the datedates of the consolidated financial statements, andas well as the reported amounts of revenues and expenses during the reporting period.

Significant estimates, required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.

Development StageCash and Cash Equivalents

For financial statement purposes, the Company considers all highly liquid investments with an original maturity of three months or less to be cash and cash equivalents.

10

Accounts Receivable

The Company’s policy is to maintain an allowance for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. As of September 30, 2021 and December 31, 2020, the bad debt allowance was $292,746and $148,520, respectively.

Inventories

Inventories mainly consists of health supplements, drugs, pharmaceutical and nutritional products, food and beverage, hotel supplies and consumables. Inventories are valued at the lower of average cost or market, cost being determined on a moving weighted average method at the end of the month. Management compares the cost of inventories with the net realizable value and an allowance is made for writing down inventories to market value, if lower. The Company is a development stage company as defined by section 915-10-20 ofrecorded 0inventory impairment for the FASB Accounting Standards Codification (“ASC”). Although the Company has recognized nominal amounts of revenue, it is still devoting substantially all of its efforts on establishing the business. All losses accumulated since its inception on March 1, 2004 were considered part of the Company’s development stage activities.three and nine months ended September 30, 2021 and 2020.

In June 2014,July 2015, the FASB issued Accounting Standards Update (“ASU”) No. 2014-10, Development Stage Entities2015-11, “Inventory (Topic 915): Elimination330) - Simplifying the Measurement of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities GuidanceInventory,” which requires that inventory within the scope of the guidance be measured at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in Topic 810, Consolidation.the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.

The amendments in this ASU removeProperty and Equipment

Property and equipment are stated at cost, less accumulated depreciation, and impairment losses, if any. Major repairs and betterments that significantly extend original useful lives or improve productivity are capitalized and depreciated over the definitionperiod benefited. Maintenance and repairs are expensed as incurred. When property and equipment are retired or otherwise disposed of, a development stage entitythe related cost and accumulated depreciation are removed from the Master Glossaryrespective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the straight-line method for substantially all assets with 5% salvage value and estimated lives as follows:

SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT

Office furniture5 years
Electronic equipment2-3 years
Machinery3 years
Leasehold improvements3 years
Vehicles5 years

Impairment of Long-Lived Assets

Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, but at least annually.

Recoverability of long-lived assets to be held and used is measured by comparing the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by it. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the Accounting Standards Codification, thereby removingasset exceeds its fair value. Fair value is generally determined using the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income,asset’s expected future discounted cash flows and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage.

For public business entities, those amendments are effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. The Company adopted ASU No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements. The adoption of this ASU allowsor market value, if readily determinable. Based on its review, the Company to remove the inception to date informationbelieves that, as of September 30, 2021 and all references to the development stage.December 31, 2020, there were 0significant impairments of its long-lived assets.

Income Taxes

The Company accountsIncome taxes are accounted for income taxes under Section 740-10-30 of the FASB ASC, which requires recognition of deferred tax assetsusing an asset and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.

liability method. Under this method, deferred income taxes are recognized for the tax assets and liabilities are based on theconsequences in future years of differences between the financial statement and tax bases of assets and liabilities usingand their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, in effect forapplicable to the yearperiods in which the differences are expected to reverse. Deferredaffect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets are reduced by a valuation allowance to the extentamount expected to be realized.

11

The Company follows Accounting Standards Codification (“ASC”) Topic 740, which prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 also provides guidance on recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures.

Under ASC Topic 740, when tax returns are filed, it is likely that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the consolidated financial statements in the period during which, based on all available evidence, management concludesbelieves it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.

8

Uncertain Tax Positions

The Company follows paragraph 740-10-25 of the FASB ASC. Paragraph 740-10-25-13 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained onupon examination, byincluding the taxing authorities, based onresolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the technical merits of the position. The tax benefits recognized in the financial statements from such a position should bemore-likely-than-not recognition threshold are measured based onas the largest amount of tax benefit that has a greateris more than 50% likelihoodlikely of being realized upon ultimate settlement.settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Interest associated with unrecognized tax benefits areis classified as interest expense and penalties are classified in selling, general and administrative expenses in the statementsstatement of income.

TheAt September 30, 2021 and December 31, 2020, the Company did not take any uncertain positions that would necessitate recording a tax positionsrelated liability.

Revenue Recognition

ASU No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), became effective for the Company on January 1, 2018. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of Topic 606. As revenues are and hadhave been primarily from the delivery of products and the performance of services, and the Company has no unrecognized tax liabilities or benefitssignificant post-delivery obligations, this did not result in a material recognition of revenue on the Company’s accompanying consolidated financial statements for the cumulative impact of applying this new standard. The Company made no adjustments to its previously-reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under Topic 605, Revenue Recognition.

Revenue from sale of goods under Topic 606 is recognized in a manner that reasonably reflects the provisionsdelivery of Section 740-10-25the Company’s products and services to customers in return for expected consideration and includes the following elements:

executed contract(s) with customers that the Company believes is legally enforceable;

identification of performance obligation in the respective contract;

determination of the transaction price for each performance obligation in the respective contract;

allocation of the transaction price to each performance obligation; and

recognition of revenue only when the Company satisfies each performance obligation.

12

The Company’s revenue recognition policies for its various operating segments are as follows:

Advertising and Products

Advertising Revenue

Commencing in the third quarter of 2019, AiXin Zhonghong began to provide advertising services to its clients. Advertising contracts are signed to establish the price and advertising services to be provided. Pursuant to the advertising contracts, the Company provides advertising and marketing services to its clients through exhibition events, conferences, and person-to-person marketing. The Company performs a credit assessment of the customer to assess the collectability of the contract price prior to entering into contracts.

Most of the advertisement contracts designated that the Company perform such advertising services for its clients through exhibition events, conferences, and person-to-person marketing during the contracted period, regardless of the number of such events. As such, the Company determined that the performance obligation is satisfied over time during the contracted period and revenue is recognized accordingly. Such advertising revenue amounted to $445,215 and $673,978 for the three months ended September 30, 2021 and 2020, respectively. Such advertising revenue amounted to $1,742,896 and $1,597,330 for the nine months ended September 30, 2021 and 2020, respectively.

A smaller proportion of the Company’s advertising revenue is generated from services to its clients through exhibition events, conferences, and person-to-person marketing, and charges based on the number of promotional products sold. Such advertising revenue amounted to $0 for the three months ended September 30, 2021 and 2020. Such advertising revenue amounted to $0 and $6,476 for the nine months ended September 30, 2021 and 2020, respectively.

All of the advertising revenue is subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China.

Products Revenue

The Company’s revenue from sale of products is recognized when goods are delivered to the customer and no other obligation exists. The Company does not provide unconditional return or other concessions to the customer. The Company’s sales policy allows for the return of unopened products for cash after deducting certain service and transaction fees. As an alternative to the product return option, the customers have options of asking for an exchange for products with the same value.

Sales revenue of AiXin Zhonghong represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 17% of the gross sales price prior to May 1, 2018, 16% since May 1, 2018 and 13% since April 1, 2019. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China. The Company records VAT payable and VAT receivable net of payments in the financial statements. The VAT tax return is filed offsetting the payables against the receivables. Sales and purchases are recorded net of VAT collected and paid as the Company acts as an agent for the government.

Hotel

Hotel revenues are primarily derived from the rental of rooms, food and beverage sales and other ancillary goods and services, including but not limited to souvenir, parking and conference reservation. Each of these products and services represents a distinct performance obligation and, in exchange for these services, the Company receives fixed amounts based on published rates or negotiated contracts. Payment is due in full at November 30, 2017the time when the services are rendered or May 31, 2017. the goods are provided. Room rental revenue is recognized on a daily basis when rooms are occupied. Food and beverage revenue and other goods and services revenue are recognized when they have been delivered or rendered to the guests as the respective performance obligations are satisfied. All of the hotel’s goods sold in China are subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China.

Pharmacies

The tax years 2014-2016 remain openCompany’s retail drugstores (Aixintang Pharmacies) recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation. Aixintang Pharmacies generally receives payments from customers as it satisfies its performance obligations. The Company records a receivable when it has an unconditional right to examinationreceive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of VAT. All of Aixintang Pharmacies’ products sold in China are subject to the PRC VAT of 0% as it qualifies for federal income tax purposessmall businesses.

13

Concentration of Credit Risk

The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy.

The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB 500,000($72,500) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on its cash in these bank accounts.

During the three months ended September 30, 2021, the Company had two major customers that accounted for over 10% of its total revenue.

SCHEDULE OF CONCENTRATION OF CREDIT RISK

Customer 

Net sales for the
three months ended
September 30, 2021

  % of total revenue 
B $299,076   37%
A*  146,140   18%

During the nine months ended September 30, 2021, the Company had two major customers that accounted for over 10% of its total revenue.

Customer 

Net sales for the
nine months ended September 30, 2021

  % of total revenue 
A* $1,152,208   49%
B  590,688   25%

During the three months ended September 30, 2020, the Company had one major customer that accounted for over 10% of its total revenue.

Customer 

Net sales for the
three months ended
September 30, 2020

  % of total revenue 
A* $673,978   92%
         

During the nine months ended September 30, 2020, the Company had one major customer that accounted for over 10% of its total revenue.

Customer 

Net sales for the
nine months ended
September 30, 2020

  % of total revenue 
A* $1,603,806   90%
         

During the three months ended September 30, 2021, the Company had no supplier that accounted for over 10% of its total purchases.

14

During the nine months ended September 30, 2021, the Company had one major supplier that accounted for over 10% of its total purchases.

Supplier 

Net purchases for the nine months ended
September 30, 2021

  % of total purchase 
C $232,584   69%
         

During the three months ended September 30, 2020, the Company had one major supplier that accounted for over 10% of its total purchases.

Supplier Net purchase for the three months ended
September 30, 2020
  % of total purchase 
D $12,087   14%
         

During the nine months ended September 30, 2020, the Company had three major suppliers that accounted for over 10% of its total purchases.

Supplier Net purchase for the nine months ended
September 30, 2020
  % of total purchase 
A* $48,137   55%
E  19,746   23
D  12,087   14%

*Represented advertising revenues from this customer during the three and nine months ended September 30, 2021 and 2020. The Company also purchased inventory from this customer in the three and nine months ended September 30, 2021 and 2020.

Leases

The Company adopted FASB Accounting Standards Codification, Topic 842, Leases (“ASC 842”) using the modified retrospective approach, electing the practical expedient that allows the Company not to restate prior to the adoption of the standard on January 1, 2019.

The Company applied the following practical expedients in the transition to the new standard allowed under ASC 842:

Practical ExpedientDescription
Reassessment of expired or existing contractsThe Company elected not to reassess, at the application date, whether any expired or existing contracts contained leases, the lease classification for any expired or existing leases, and the accounting for initial direct costs for any existing leases.
Use of hindsightThe Company elected to use hindsight in determining the lease term (that is, when considering options to extend or terminate the lease and to purchase the underlying asset) and in assessing impairment of right-to-use assets.
Reassessment of existing or expired land easementsThe Company elected not to evaluate existing or expired land easements that were not previously accounted for as leases under ASC 840, as allowed under the transition practical expedient. Going forward, new or modified land easements will be evaluated under ASU No. 2016-02.
Separation of lease and non-lease componentsLease agreements that contain both lease and non-lease components are generally accounted for separately.
Short-term lease recognition exemptionThe Company also elected the short-term lease recognition exemption and will not recognize ROU assets or lease liabilities for leases with a term less than 12 months.

15

The Company determines if an arrangement is a lease at inception under FASB ASC Topic 842, Right of Use Assets (“ROU”) and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As most of its leases do not provide an implicit rate, it uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The ROU assets include adjustments for prepayments and accrued lease payments. The ROU asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that it will exercise such options.

ROU assets are reviewed for impairment when indicators of impairment are present. ROU assets from operating and finance leases are subject to the impairment guidance in ASC 360, Property, Plant, and Equipment, as ROU assets are long-lived nonfinancial assets.

ROU assets are tested for impairment individually or as part of an asset group if the cash flows related to the ROU asset are not independent from the cash flows of other major taxing jurisdictionsassets and liabilities. An asset group is the unit of accounting for long-lived assets to be held and used, which represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. The Company recognized no impairment of ROU assets as of September 30, 2021 and December 31, 2020. Operating leases are included in operating lease ROU and operating lease liabilities (current and non-current), on the consolidated balance sheets.

Statement of Cash Flows

In accordance with ASC Topic 230, “Statement of Cash Flows,” cash flows from the Company’s operations are calculated based on the local currencies using the average translation rates. As a result, amounts related to assets and liabilities reported on the consolidated statements of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

Fair Value of Financial Instruments

The carrying amounts of certain of the Company’s financial instruments, including cash and equivalents, accrued liabilities and accounts payable, approximate their fair value due to their short maturities. FASB ASC Topic 825, “Financial Instruments,” requires disclosure of the fair value of financial instruments held by the Company. The carrying amounts reported in the consolidated balance sheets for current liabilities each qualify as financial instruments and are a reasonable estimate of their fair value because of the short period of time between the origination of such instruments and their expected realization and the current market rate of interest.

16

Fair Value Measurements and Disclosures

ASC Topic 820, “Fair Value Measurements and Disclosures,” defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The three levels are defined as follow:

Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.

As of September 30, 2021 and December 31, 2020, the Company did not identify any assets and liabilities that are required to be presented on the balance sheet at fair value.

Foreign Currency Translation and Comprehensive Income (Loss)

The functional currency of the Company is subject.RMB. For financial reporting purposes, RMB is translated into USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet dates. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period.

LossTranslation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity as “Accumulated other comprehensive income”. Gains and losses resulting from foreign currency transactions are included in income. There was no significant fluctuation in the exchange rate for the conversion of RMB to USD after the balance sheet date.

The Company uses FASB ASC Topic 220, “Comprehensive Income”. Comprehensive loss is comprised of net loss and all changes to the statements of stockholders’ equity, except those due to investments by stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive income (loss) for the three and nine months ended September 30, 2021 and 2020 consisted of net income (loss) and foreign currency translation adjustments.

Earnings per Share

Basic lossincome (loss) per share wasis computed by dividingon the loss for each period applicable to the common shareholders bybasis of the weighted average number of common shares outstanding during the period. There

Dilution is computed by applying the treasury stock method for options and warrants. Under this method, options and warrants are no outstandingassumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock equivalents forat the sixaverage market price during the period.

As of September 30, 2021 and three months ended November 30, 2017 or 2016 and they are thusDecember 31, 2020, the Company did not considered.have any potentially dilutive instruments.

Concentration of Credit RiskStock-Based Compensation

The Company has no significant off-balance-sheet concentrations of credit risk suchperiodically grants stock options, warrants and awards to employees and non-employees in non-capital raising transactions as foreign exchange contracts, options contracts or other foreign hedging arrangements.

Fair Value of Financial Instruments

compensation for services rendered. The carrying value of cashCompany accounts for stock option, stock warrant and accrued expenses, if applicable, approximate their fair valuesstock award grants to employees based on the short-term maturityauthoritative guidance provided by the FASB where the value of these instruments. The carrying amountsthe award is measured on the date of debt were also estimated to approximate fair value.

grant and recognized over the vesting period. The Company utilizesaccounts for stock option, stock warrant and stock award grants to non-employees in accordance with the methodsauthoritative guidance of fairthe FASB where the value (“FV”)of the stock compensation is determined based upon the measurement as describeddate at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the employees and non-employees, option, warrant and award grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

17

Segment Reporting

ASC 820 to value its financial assets and liabilities. As defined in ASC 820, FVTopic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the price that would be received to sell an asset or paid to transferway a liability in an orderly transaction between market participants atcompany’s chief operating decision maker organizes segments within the measurement date. In order to increase consistencyCompany for making operating decisions assessing performance and comparability in FV measurements, ASC 820 establishes a FV hierarchy that prioritizes observable and unobservable inputs used to measure FV into three broad levels, which are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The FV hierarchy gives the highest priority to Level 1 inputs.

Level 2: Observable prices thatallocating resources. Reportable segments are based on inputs not quoted on active markets, but corroboratedproducts and services, geography, legal structure, management structure, or any other manner in which management disaggregates a company.

The Company manages its business as three operating segments, advertising and products, pharmacies, and hotels, all of which are located in the PRC. All of its revenues are derived in the PRC. All long-lived assets are located in PRC.

The following table shows the Company’s operations by market data.business segment for the three months ended September 30, 2021 and 2020:

Level 3: Unobservable inputs are used when little or no market data is available.

SCHEDULE OF SEGMENT REPORTING

  2021  2020 
Net revenue        
Advertising and products $509,861  $728,896 
Pharmacies  139,947   - 
Hotel  163,102   - 
Total revenues, net $812,910  $728,896 
         
Operating costs and expenses        
Advertising and products        
Cost of goods sold $38,461  $20,478 
Operating expenses  267,331   389,141 
Pharmacies        
Cost of goods sold  92,477   - 
Operating expenses  124,138   - 
Hotel        
Hotel operating costs  320,305   - 
Operating expenses  63,707   - 
Total operating costs and expenses $906,419  $409,619 
         
Income (loss) from operations        
Advertising and products $204,069  $319,277 
Pharmacies  (76,668)  - 
Hotel  (220,910)  - 
Income (loss) from operations $(93,509) $319,277 

The FV hierarchy givesfollowing table shows the lowest priority to Level 3 inputs.Company’s operations by business segment for the nine months ended September 30, 2021 and 2020.

  2021  2020 
Net revenue        
Advertising and products $2,060,787  $1,774,139 
Pharmacies  139,947   - 
Hotel  163,102   - 
Total revenues, net $2,363,836  $1,774,139 
         
Operating costs and expenses        
Advertising and products        
Cost of goods sold $199,141  $67,379 
Operating expenses 966,903  1,054,869 
Pharmacies      
Cost of goods sold  92,477   - 
Operating expenses  124,138   - 
Hotel      
Hotel operating costs  320,305   - 
Operating expenses  63,707   - 
Total operating costs and expenses $1,766,671  $1,122,248 
         
Income (loss) from operations        
Advertising and products $894,743  $651,891 
Pharmacies  (76,668)  - 
Hotel  (220,910)  - 
Income (loss) from operations $597,165  $651,891 

18
 9

Related Parties

Segment assets As of
September 30, 2021
  As of
December 31, 2020
 
Advertising and products $3,775,971  $8,093,818 
Pharmacies  797,105   - 
Hotel  2,091,486   - 
Total assets $6,664,562  $8,093,818 

The Company follows subtopic 850-10 of the FASB ASC for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 related parties include: a. affiliates of the Company; b. entities for which investments in their equity securities would be required, absent the election of the FV option under the FV Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of financial statements is not required in those statements.

The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Commitments and Contingencies

The Company follows subtopic 450-20 of the FASB ASC to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates it is probable a material loss was incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

New Accounting Pronouncements

In AugustJune 2016, the FASB issued ASU No. 2016-15, Classification2016-13, Financial Instruments-Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of Certain Cash Receipts and Cash Payments. ASU 2016-15 clarifies the presentation and classification of certain cash receipts and cash payments in the statement of cash flows.credit losses on financial assets measured at amortized cost. This ASUguidance is effective for public businessfiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early application will be permitted for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017.2018. The Company does not anticipateis currently evaluating the impact that the adoption of this ASUstandard will have a significant impact on its consolidated financial statements.

In November 2016,August 2020, the FASB issued ASU No. 2016-18, Statement2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for convertible debt by eliminating the beneficial conversion and cash conversion accounting models. Upon adoption of Cash Flows (Topic 230): Restricted Cash. The guidanceASU 2020-06, convertible debt, unless issued with a substantial premium or an embedded conversion feature that is not clearly and closely related to the host contract, will no longer be allocated between debt and equity components. This modification will reduce the issue discount and result in less non-cash interest expense in financial statements. ASU 2020-06 also updates the earnings per share calculation and requires that a statement of cash flows explainentities to assume share settlement when the change during the periodconvertible debt can be settled in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally describedshares. For contracts in an entity’s own equity, the type of contracts primarily affected by ASU 2020-06 are freestanding and embedded features that are accounted for as restricted cashderivatives under the current guidance due to a failure to meet the settlement assessment by removing the requirements to (i) consider whether the contract would be settled in registered shares, (ii) consider whether collateral is required to be posted, and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The standard(iii) assess shareholder rights. ASU 2020-06 is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years.2023. Early adoption is permitted, including adoption in an interim period. The standard should be applied using a retrospective transition method to each period presented.but no earlier than fiscal years beginning after December 15, 2020, and only if adopted as of the beginning of such fiscal year. The Company does not anticipate theadopted ASU 2020-06 effective July 1, 2021. The adoption of this ASU will2020-06 did not have a significantany impact on itsthe Company’s consolidated financial statements.statements presentation or disclosures.

10

In January 2017,May 2021, the FASB issued ASU No. 2017-01, Business Combinations2021-04, Earnings Per Share (Topic 805)260), Debt — Modifications and Extinguishments (Subtopic 470-50), Compensation — Stock Compensation (Topic 718), and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): ClarifyingIssuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (“ASU 2021-04”). ASU 2021-04 provides guidance as to how an issuer should account for a modification of the Definitionterms or conditions or an exchange of a Business, which clarifiesfreestanding equity-classified written call option (i.e., a warrant) that remains classified after modification or exchange as an exchange of the definitionoriginal instrument for a new instrument. An issuer should measure the effect of a business withmodification or exchange as the objectivedifference between the fair value of adding guidancethe modified or exchanged warrant and the fair value of that warrant immediately before modification or exchange and then apply a recognition model that comprises four categories of transactions and the corresponding accounting treatment for each category (equity issuance, debt origination, debt modification, and modifications unrelated to assist entities with evaluating whether transactions should be accounted for as acquisitionsequity issuance and debt origination or disposals of assets or businesses. The standardmodification). ASU 2021-04 is effective for all entities for fiscal years beginning after December 15, 2017,2021, including interim periods within those fiscal years. Early adoption is permitted. The standardAn entity should be appliedapply the guidance provided in ASU 2021-04 prospectively to modifications or exchanges occurring on or after the effective date. The Company willEarly adoption is permitted for all entities, including adoption in an interim period. If an entity elects to early adopt this ASU for its2021-04 in an interim period, the guidance should be applied as of the beginning of the fiscal year beginning January 1, 2018.that includes that interim period. The adoption of ASU 2021-04 is not expected to have any impact on the Company’s consolidated financial statements presentation or disclosures.

The Company has reviewed allCompany’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements and have determined that these new accounting pronouncements are either not applicable orauthoritative guidance, if currently adopted, would not have a material impact on the results of operationsCompany’s financial statement presentation or changes in the financial position.disclosures.

NOTE 2 - RELATED PARTY TRANSACTIONS3. ADVANCES TO SUPPLIERS

As of November 30, 2017, theThe Company had dueadvances to related partiessuppliers of $248,265,$279,859and $155,686as of which, 1) $164,877 was dueSeptember 30, 2021 and December 31, 2020, respectively. Advances to China Concentric as a result of an assignment of rightssuppliers primarily include prepayments for products expected to advances previously made by Algodon, the Company’s former parent. The assignment of rights was made concurrent with the sale by Algodon of its shares in the Companybe delivered subsequent to China Concentric on January 20, 2017. This advance carries no interest. 2) $1,800 advanced to the Company for paying certain company’s expenses by Mr. Zhu, a shareholderbalance sheet dates.

4. INVENTORIES

Inventories consisted of the Company. 3) $81,588 advanced to the Company for paying G&A expenses by an officer of the Company.following at September 30, 2021 and December 31, 2020:

SCHEDULE OF INVENTORY

  September 30, 2021  December 31, 2020 
Finished goods – health supplements $103,334  $45,535 
Drugs, pharmaceutical and nutritional products  105,304   - 
Food and beverage, hotel supplies and consumables  110,967   - 
Total $319,605  $45,535 

As of May 31, 2017, the Company had 1) advances due China Concentric of $164,877. This total advance, which was assigned to China Concentric by Algodon, carries no interest. 2) $1,800 advanced to the Company for paying certain Company expenses by Mr. Zhu, a shareholder of the Company.

NOTE 3 - INCOME TAXES

As of November 30, 2017, the Company had a net operating loss (“NOL”) carry-forward for income tax reporting purposes of approximately $451,915 that may be offset against future taxable income through 2036. Current tax laws limit the amount of loss available to be offset against future taxable income when a substantial change in ownership occurs. Therefore, the amount available to offset future taxable income may be limited. No tax benefit has been reported in the financial statements, because the Company believes there is a 50% or greater chance that the realization of the Company’s net deferred tax assets resulting from NOL carry-forwards will expire unused. Accordingly, the potential tax benefits of the loss carry-forwards are offset by a valuation allowance of the same amount.

Components of deferred tax assets are as follows:

  November 30, 2017  May 31, 2017 
Expected income tax benefit from NOL carry-forwards $141,671  $123,180 
Less: valuation Allowance  (141,671)  (123,180)
Net deferred tax assets – Non-current: $-  $- 

19
 11

The provision for income taxes differs from5. PROPERTY AND EQUIPMENT, NET

Property and equipment consisted of the amount computed using the federal US statutory income tax rate for the six months ended Novemberfollowing at September 30, 20172021 and 2016 is as follows:December 31, 2020:

SCHEDULE OF PROPERTY AND EQUIPMENT

  September 30, 2021  December 31, 2020 
Vehicles $292,259  $288,604 
Office furniture  63,557   48,464 
Electronic equipment  21,882   14,852 
Machinery  103,747   - 
Construction in progress  253,729   - 
Other  6,304   - 
Total  741,478   351,920 
Less: Accumulated depreciation  (382,066)  (284,103)
Property and equipment, net $359,412  $67,817 

  2017  2016 
Provision (Benefit) at US Statutory Rate $(18,491) $(7,095)
Increase (Decrease) in Valuation Allowance  18,491   7,095 
  $-  $- 

The provision for income taxes differs from the amount computed using the federal US statutory income tax rateDepreciation expense for the three months ended NovemberSeptember 30, 20172021 and 2016 is as follows2020 was $10,608 and $9,761, respectively. Depreciation expense for the nine months ended September 30, 2021 and 2020 was $21,478 and $34,572, respectively.

6. INTANGIBLE ASSET, NET

Intangible asset consisted of the following at September 30, 2021 and December 31, 2020:

SCHEDULE OF INTANGIBLE ASSETS

  September 30, 2021  December 31, 2020 
Software $7,809  $- 
Less: Accumulated amortization  (5,240)    
Intangible asset, net $2,569  $- 

Amortization expense for the three and nine months ended September 30, 2021 was $432.

 

  2017  2016 
Provision (Benefit) at US Statutory Rate $(6,970) $(4,063)
Increase (Decrease) in Valuation Allowance  6,970   4,063 
  $-  $- 

7. TAXES PAYABLE

The Company evaluates its valuation allowance requirements based on projected future operations. When circumstances change and cause a change in management’s judgment about the recoverability of deferred tax assets, the impact

Taxes payable consisted of the change on the valuation is reflected in current income.following at September 30, 2021 and December 31, 2020:

SCHEDULE OF TAXES PAYABLE

  September 30, 2021  December 31, 2020 
Value-added $66,178  $32,318 
Income  248,071   235,300 
City construction  4,794   2,422 
Education  2,085   1,781 
Other  13,389   11,674 
Taxes payable $334,517  $283,495 

20

NOTE 4 – CHANGE IN CONTROL8. ACCRUED LIABILITIES AND OTHER PAYABLES

On January 20, 2017, Algodon Wines & Luxury Development Group, Inc. (“Algodon”), the owner of at least 43,822,001 shares (the “Algodon Shares”), or 96.5%Accrued liabilities and other payables consisted of the outstanding common stockfollowing at September 30, 2021 and December 31, 2020:

SCHEDULE OF ACCRUED LIABILITIES AND OTHER PAYABLES

  September 30, 2021  December 31, 2020 
Accrued employees’ social insurance $348,650  $364,870 
Accrued payroll and commission  232,417   105,844 
Accrued rent expense  101,228   - 
Construction payable  76,437   - 
Accrued professional fees  45,569   16,927 
Deposit  7,450   - 
Other payables  

33,040

   26,598 
Total $844,791  $514,239 

9. LOAN FROM THIRD PARTIES

As of September 30, 2021 and December 31, 2020, the Company had advances from former shareholders and unrelated third parties of Aixin Shangyan Hotel in an aggregate amount of $463,229 and $0, respectively. There was no written agreement, and these loans are payable on demand and bear no interest.

10. LEASE

On September 12, 2018, the Company entered into a contract to sell its rights to a portion of a building with a buyer (the “Buyer”), at which time the Buyer paid RMB 100,000 ($14,898) to a shareholder of the Company soldas a down payment. The contract stipulated the Algodon Sharesremaining RMB 8,900,000 ($1,325,964) should be paid by the Buyer on or before September 30, 2018 and before the Company would be required to China Concentric Capital Group Ltd., a British Virgin Islands company (“China Concentric”), for $260,000 pursuant to a Stock Purchase Agreement dated December 20, 2016, as amended. Algodon also assigned to China Concentric all its right, title and interest to amounts payable to Algodon for non-interest bearing advancesgo to the relevant authority to effectuate the transfer of its property rights. The Buyer failed to make the payment on or prior to September 30, 2018, a default under the contract which gave the Company the right to terminate the contract. In October 2018, the Buyer delivered to the shareholder an additional RMB 7 million ($1.0 million). On March 25, 2019, the parties entered into a supplemental agreement which advances, as of January 20, 2017 were $164,877.

On February 2, 2017, China Concentric soldprovided that the Company would transfer the property rights to Mr. Quanzhong Lin, an entrepreneur resident inBuyer if it agreed the People’s Republic of China, 29,521,410Company would get the benefit of the shares it purchased from Algodon, approximately 65%RMB 7,000,000 ($1,042,893) and otherwise pay the remaining balance of RMB 1,200,000 ($178,782) on or prior to March 31, 2019. The RMB 1,200,000 ($178,782) was paid directly to the shareholder on a timely basis and the Company was given the benefit of the outstanding sharesRMB 8,900,000 ($1,325,964) delivered to the Shareholder.The cost and accumulated depreciation of the Company’s common stock, for $300,000, pursuantbuilding was $1,739,228 and $364,834, respectively. The Company recorded a loss on sale of $32,945 during the nine months ended September 30, 2019. $1,340,862 of the proceeds from the sale was collected by the principal shareholder which was offset against amounts due to a Stock Purchase Agreement dated December 21, 2016.the shareholder.

Mr. Lin indicated he is purchasing a controlling interest in the CompanyConcurrent with the intentioncompletion of acquiring an operating business in a reverse acquisition transaction through a share exchange. There can be no assurance that an acquisition of any particular business will be consummated.

On July 21, 2017,this sale, the Company entered into an agreement to lease a portion of the building back from the Buyer over a lease term of 2years. The Company accounted for this lease as an operating lease right-of-use asset and a corresponding operating lease liability in accordance with the Lease Standard. As a result, $207,049 (RMB 1,389,731) was recorded as operating lease right-of-use asset and lease liability on March 31, 2019 when the lease commenced based on a 4.75% discount factor. The lease agreement expired on March 31, 2021. Commencing in April, 2021, the Company continues to lease the office on a monthly basis.

21

The Company also has operating leases for other sales locations under various operating lease arrangements. The leases have remaining lease terms of approximately 1 month to 5 years.

Aixin Shangyan Hotel leases its hotel premises under an operating lease arrangement. The lease has a remaining lease term of approximately 2.25 years.

Aixintang Pharmacies lease retail pharmacy stores under operating lease arrangements, typically with initial terms of 2 to 5 years.

Balance sheet information related to the Company’s leases is presented below:

SCHEDULE OF OPERATING LEASE LIABILITIES

  September 30, 2021  December 31, 2020 
Operating Leases        
Operating lease right-of-use assets $2,050,023  $100,029 
         
Operating lease liabilities – current $844,093  $70,780 
Operating lease liability – non-current  1,205,932   29,250 
Total operating lease liabilities $2,050,025  $100,030 

The following provides details of the Company’s lease expenses:

SCHEDULE OF OPERATING LEASE EXPENSES

  Three Months Ended September 30, 
  2021  2020 
Operating lease expenses $161,389  $13,878 

  Nine Months Ended September 30, 
  2021  2020 
Operating lease expenses $217,642  $66,622 

Other information related to leases is presented below:

SCHEDULE OF OTHER INFORMATION RELATED LEASES

  Nine Months Ended September 30, 
  2021  2020 
Cash Paid For Amounts Included In Measurement of Liabilities:      
Operating cash flows from operating leases $217,642   66,622 
         
Weighted Average Remaining Lease Term:        
Operating leases  2.42 years   1.39 years 
         
Weighted Average Discount Rate:        
Operating leases  4.75%  4.75%

Maturities of lease liabilities were as follows:

SCHEDULE OF MATURITIES OF LEASE LIABILITIES

For the year ending December 31:   
2021 (excluding the nine months ended September 30, 2021) $225,202 
2022  920,209 
2023  912,194 
2024  63,731 
2025  30,774 
Thereafter  14,206 
Total lease payments  2,166,316 
Less: imputed interest  (116,291)
Total lease liabilities  2,050,025 
Less: current portion  (844,093)
Lease liabilities – non-current portion $1,205,932 

22

11. RELATED PARTY TRANSACTIONS

Advance to related parties

SCHEDULE OF RELATED PARTY TRANSACTIONS

Advance to related parties consisted of the following as of the periods indicated:

  September 30, 2021  December 31, 2020 
Chengdu WenJiang Aixin Nanjiang Pharmacy Co., Ltd. $5,447  $- 
Qionglai Weide Pharmacy  -   10,421 
Chengdu Xindu Cundetang Pharmacy Co., Ltd.  -   5,318 
Chengdu Lisheng Huiren Tang Pharmacy Co., Ltd.  10,060   - 
Total $15,507  $15,739 
Advance to related parties  15,507   15,739 

Advance from related parties

Advance from related parties consisted of the following as of the periods indicated:

  September 30, 2021  December 31, 2020 
Quanzhong Lin $-  $258,862 
Yirong Shen  96,222   - 
Chengdu Aixin E-Commerce Company Ltd.  12,718   3,240 
Chengdu Aixin International travel service Co, Ltd  1,430   - 
Chengdu Beibang Pharmacy  -   2,748 
Aixin Life Beauty  7,638   - 
Total $118,008  $264,850 
Advance from related parties  118,008   264,850 

All the related party entities are controlled by Mr. Quanzhong Lin (the Chairman, President and major shareholder of Aixin Life). These advances to and from related parties were for working capital purpose, payable on demand, and bear no interest. Yirong Shen was a major shareholder of Aixin Shangyan Hotel prior to the closing of Hotel Purchase Agreement, and Planshe serves as the supervisor of Merger pursuant to which the Company would be merged with and intoAixin Shangyan Hotel.

Office lease from a newly-formed wholly-owned subsidiary, AiXin Life International, Inc., a Nevada corporation, as a result of which the Company’s state of incorporation would be changed from Colorado to Nevada. The Merger was subject to approval by the Financial Regulatory Authority. On August 25, 2017, the Company terminated the Agreement and Plan of Merger with its newly-formed wholly-owned subsidiary, AiXin Life International, Inc., as a result of which it would have become a Nevada corporation.Major Shareholder

NOTE 5 – SUBSEQUENT EVENT

On December 12, 2017,In May 2014, the Company entered into and closed a share exchange agreement,lease with AiXin (BVI) International Group Co., Ltd. a British Virgin Islands corporation (“AiXin BVI”its major shareholder for office use; the lease term was three yearsuntil May 2017 with an option to renew. The monthly rent was RMB 5,000 ($774), and Quanzhong Lin, the sole stockholder of AiXin BVI (the “AiXin BVI Stockholder”), pursuant to which the Company acquired 100%was required to prepay each year’s annual rent at 15th of May of each year. The Company renewed the lease until May 28, 2023with monthly rents of RMB 5,000 ($774), payable quarterly.The future annual minimum lease payment at September 30, 2021 is $9,311 and $6,208 for each of the outstanding capital stockyear ended September 30, 2022 and 2023, respectively.

12. INCOME TAXES

The Company was incorporated in the United States of AiXin BVIAmerica (“USA”) and has operations in one tax jurisdiction, i.e. the PRC. The Company generated substantially all of its sales from its operations in the PRC for 227,352,604 sharesthe three and nine months ended September 30, 2021 and 2020, and recorded an income tax provision for each of such periods.

China has a tax rate of 25% for all enterprises (including foreign-invested enterprises).

Uncertain Tax Positions

Interest associated with unrecognized tax benefits are classified as income tax, and penalties are classified in selling, general and administrative expenses in the Company’s common stock (the “Share Exchange” orstatements of operations. For the “AiXin Acquisition”). After giving effect to the Share Exchange,three and nine months ended September 30, 2021 and 2020, the Company had outstanding 317,988,089 shares of common stock.no unrecognized tax benefits and related interest and penalties expenses. Currently, the Company is not subject to examination by major tax jurisdictions.

23
 12

13. STOCKHOLDERS’ EQUITY

AsOn August 17, 2020, by unanimous written consent in lieu of a resultmeeting, the Board adopted resolutions authorizing a one (1)-for-four (4) reverse stock splitand on August 19, 2020 filed Articles of Amendment to effect the reverse stock split with the Secretary of State of the Share Exchange, AiXin BVIState of Colorado. The reverse stock split became effective on October 27, 2020. According to the Articles of Amendment, the Company is authorized to issue 20,000,000shares of blank check preferred stock at $0.001 par value and to reduce the number of authorized common stock to 500,000,000 shares at $.00001 par value per share from 950,000,000shares. All share and earnings per share information has been retroactively adjusted to reflect the reverse stock split.

As of September 30, 2021 and December 31, 2020, the Company had 49,999,891common shares issued and outstanding.

In June 2020, 35,049,685 shares owned by Quanzhong Lin (the Chairman, President and major shareholder of Aixin Life) were cancelled.

Stock Awards Issued for Services

On October 22, 2019, the Company granted and issued 37,500 shares to its employees and contractors under its 2019 Equity Incentive Plan. The stock awards were valued at $337,500 based on the post-split closing price of $9 on the grant date.

On October 24, 2019, the Company granted and issued 550,000 shares to its employees and contractors under its 2019 Equity Incentive Plan. The stock awards were valued at $1,520,200 based on the post-split closing price of $2.764 on the grant date.

The stock awards will vest over five (5) years from the grant date, and the grantee will forfeit a portion of the shares granted (“Shares Granted”) if the grantee is no longer employed by or contracted with the Company. Specifically, the grantee will forfeit 80% of Shares Granted if no longer employed by or contracted with the Company on the date that is one year from the grant date, forfeit 60% of Shares Granted if no longer employed by or contracted with the Company on the date that is two years from the grant date, forfeit 40% of Shares Granted if no longer employed by or contracted with the Company on the date that is three years from the grant date, and forfeit 20% of Shares Granted if no longer employed by or contracted with the Company on the date that is four years from the grant date. Effective on the 5th year from the grant date, none of the shares will be subject to forfeiture.

For the three months ended September 30, 2021 and 2020, stock-based compensation expenses were $92,885. For the nine months ended September 30, 2021 and 2020, stock-based compensation expenses were $278,655. As of September 30, 2021, unrecognized compensation expenses related to these stock awards are $1,137,092. These expenses are expected to be recognized over 4 years.

Forgiveness of shareholder’s loan

As of September 30, 2021, the Company’s wholly-owned subsidiary, andmajor shareholder Mr. Lin forgave his loan to the Company now owns allfor $2,448,654. The Company recorded this forgiveness of shareholder loan as additional paid-in capital.

Acquisition of Subsidiaries

As of September 30, 2021, the outstanding sharesCompany completed the acquisition of HK AiXin International Group Co.Aixin Shangyan Hotel and Aixintang Pharmacies (see Note 1), Limited, a Hong Kong limited company (“AiXin HK”), which in turn owns all of the outstanding shares of Chengdu AiXin Zhonghong Biological Technology Co., Ltd., a Chinese limited company (“AiXin Zhonghong”), which markets and sells innovative, premium-quality nutritional products in Chengdu, China.

AiXin BVI was incorporated on September 21, 2017 to serve as a holding company and AiXin HK was established in Hong Kong on February 25, 2016 to serve as an intermediate holding company. AiXin Zhonghong was established in the PRC on March 4, 2013, and on June 1, 2017 the local government of the PRC issued a certificate of approval regarding the foreign ownership of AiXin Zhonghong by AiXin HK. Neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017.

Prior to the AiXin Acquisition, Quanzhong Lin, the Company’s President and Chief Executive Officer, owned all of the outstanding shares of AiXin BVI and 29,521,410 shares of the Company’s common stock, approximately 65% of the outstanding shares of the Company. As a result of the Share Exchange, Mr. Lin now owns 256,874,014 shares of the Company’s common stock, approximately 80.78% of the Company’s outstanding shares.

For accounting purposes, the acquisition was accounted for as entities under common control. Pursuant to the acquisition, the Company made payment to Mr. Lin in the aggregate amount of $4,497,972, or RMB 29 million. The difference between consideration given and net assets received was recognized in equity, resulting in a reverse acquisitiondecrease of additional paid-in capital of $4,257,275.

14. STATUTORY RESERVES

Pursuant to the PRC corporate law, the Company is now only required to maintain one statutory reserve by appropriating from its after-tax profit before declaration or payment of dividends. The statutory reserve represents restricted retained earnings.

24

Surplus reserve fund

The Company is now required to transfer 10% of its net income, as determined under PRC accounting rules and was treated asregulations, to a recapitalization of Mercari Communications Group, Ltd. effected by a share exchange, with AiXin BVI as the accounting acquirer. Since neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017, the historical financial statements of AiXin Zhonghong are now the historical financial statementsstatutory surplus reserve fund until such reserve balance reaches 50% of the registrant, Mercari Communications Group, Ltd. Company’s registered capital. During the three and nine months ended September 30, 2021 and 2020, the Company did not make any contribution to statutory reserve fund.

The surplus reserve fund is non-distributable other than during liquidation and can be used to fund previous years’ losses, if any, and may be utilized for business expansion or converted into share capital by issuing new shares to existing shareholders in proportion to their shareholding or by increasing the par value of the shares currently held by them, provided that the remaining reserve balance after such issue is not less than 25% of the registered capital.

Common welfare fund

Common welfare fund is a voluntary fund to which the Company can elect to transfer 5% to 10% of its net income, as determined under PRC accounting rules and regulations. The Company did not make any contribution to this fund during the three and nine months ended September 30, 2021 and 2020.

This fund can only be utilized on capital items for the collective benefit of the Company’s employees, such as construction of dormitories, cafeteria facilities, and other staff welfare facilities. This fund is non-distributable other than upon liquidation.

15. OPERATING CONTINGENCIES

The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments and foreign currency exchange. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.

The Company’s sales, purchases and expenses are denominated in RMB and all of the Company’s assets and liabilities are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation to affect the remittance.

Litigation

The Company is, from time to time, involved in litigation incidental to the conduct of its business regarding merchandise sold, employment matters, and litigation regarding intellectual property rights.

In December 2020, Jian Yiao (the “Plaintiff”) filed a complaint against Chengdu Aixintang Pharmacy Co., Ltd. (“Aixintang Pharmacy”, or the “Defendant”) in Zhangjiagang People’s Court in Jiangsu Province. The complaint alleges that Jian Yiao is entitled to $388,000 (RMB 2,500,000) from Aixintang Pharmacy for not fulfilling the contractual obligation of a purchase agreement entered in March 2020 (the “Purchase Agreement”). Aixintang Pharmacy claimed that the Purchase Agreement was falsely entered by an employee through forged documents, and that Aixintang Pharmacy did not enter the Purchase Agreement. The Court determined that Aixintang Pharmacy breached the Purchase Agreement by not delivering the products ordered and ordered Aixintang Pharmacy to pay $388,000 (RMB 2,500,000) to the Plaintiff. In December 2020, Aixintang Pharmacy filed a motion in the Jiangsu Suzhou Intermediate People’s Court against the determination reached from the first trial.

In February 2021, the judge in the Jiangsu Suzhou Intermediate People’s Court denied the Defendant’s motion and upheld the judgment from the first trial. In March 2021, Aixintang Pharmacy filed another motion to the Jiangsu High People’s Court on the basis that the Purchase Agreement was forged. To date, this legal proceeding remains pending.

In November 2021, the Company and Mr. Quanzhong Lin agreed that Mr. Lin shall assume any losses arising from this legal proceeding. As such, the Company did not accrue contingent losses from this legal proceeding as of September 30, 2021.

The Company believes that current pending litigation will not have a material adverse effect on its consolidated financial position, results of operations or cash flows.

16. ACQUISITION OF SUBSIDIARIES

From July and September, 2021, the Company completed the required governmental procedures and obtained the documents necessary to consider the acquisitions of Aixin Shangyan Hotel and Aixintang Pharmacies completed.

Pursuant to the Hotel Purchase Agreement dated on May 25, 2021, AiXin ZhonghongHK purchased all of the outstanding equity of Aixin Shangyan Hotel for a purchase price of RMB 7,598,887, or $1.18 million. The Transfer Price will be reduced by an amount equal to any amounts paid or distributed by Aixin Shangyan Hotel to the Transferor after December 31, 2020 and will be increased by an amount equal to any amounts contributed to Aixin Shangyan Hotel by the Transferor after December 31, 2020.

Pursuant to the Pharmacies Purchase Agreement entered on June 2, 2021, AiXin HK purchased 100% ownership of Aixintang Pharmacies from Mr. Lin and the other two shareholders for a purchase price of RMB 34,635,845 or $5.37 million. The purchase price will be reduced by an amount equal to any amounts paid or distributed by any of the Aixintang Pharmacies to Mr. Lin or the other two shareholders after December 31, 2020, and increased by an amount equal to any monies they contributed to any of the Aixintang Pharmacies after such date.

25

The acquisition is for entities under common control under ASC 805-50-15-6, and the assets and liabilities acquired will be measured and recorded at the carrying amount under ASC 805-50-30-5. The following condensed unaudited pro forma consolidated results of operations for the Company, Aixin Shangyan Hotel and Aixintang Pharmacies for the nine months ended September 30, 2021 and 2020 present the Company, Aixin Shangyan Hotel and Aixintang Pharmacies operations as if the acquisitions occurred on January 1, 2021 and 2020, respectively. The pro forma results are not necessarily indicative of the actual results that would have occurred had the acquisitions been brought forward at their book valuecompleted as of the beginning of the periods presented, nor are they necessarily indicative of future consolidated results.

SCHEDULE OF BUSINESS ACQUISITION PRO FORMA

  2021  2020 
Revenue $3,534,185  $3,525,664 
Operating costs and expenses  3,907,235   3,646,621 
Loss from operations  (373,050)  (120,957)
Other income (expense)  82,909   601,710 
Income tax expense  292,146   2,347 
Net income (loss) $(582,287) $478,406 

17. SUBSEQUENT EVENT

The Company follows the guidance in FASB ASC 855-10 for the disclosure of subsequent events. The Company evaluated subsequent events through the date the financial statements were issued and determined the Company has no goodwill has been recognized.material subsequent events.

26

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

General

The following discussion of our financial condition and results of operations should be read in conjunction with the unaudited financial statements and the notes to those statements included elsewhere in this Form 10-Q and with the audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended MayDecember 31, 20172020 (the “2017“2020 Form 10-K”). This discussion contains forward-looking statements that involve risks and uncertainties. You should specifically consider the various risk factors identified in our 20172020 Form 10-K, that could cause actual results to differ materially from those anticipated in these forward-looking statements.

PlanOverview

We market and sell consumer products in China by offering premium-quality nutritional products. We also provide advertising and marketing services to clients which engage us to distribute their products. We offer our nutritional products and those of Operationsour clients through our sales offices, exhibition events we organize and sponsor, and person-to-person marketing. Our marketing business mainly focuses on proactively approaching customers such as by hosting events for clients, which we believe is ideally suited to marketing our products and those of our clients for which we perform advertising services because sales of nutritional products are strengthened by ongoing personal contact and support, coaching and education among the Company and our clients towards how to achieve a healthy and active lifestyle.

UntilIn July we completed the acquisition of Aixin Shangyan Hotel. Shangyan Hotel Company owns and operates a hotel located in the Jinniu District, Chengdu City. The hotel covers more than 8,000 square meters and has a large restaurant that can accommodate 600 people, 6 luxury dining rooms, a 200 square meter music tea house, 13 private tea rooms, 108 guest rooms and other supporting facilities. completed. We acquired the hotel through an acquisition of the outstanding equity of Aixin Shangyan Hotel for a purchase price of RMB 7,598,887, or approximately $1.16 million (“Transfer Price”). The Transfer Price will be reduced by an amount equal to any amounts paid or distributed by the hotel to its shareholders after December 12, 2017,31, 2020 and will be increased by an amount equal to any amounts contributed to the hotel by its equity owners after December 31, 2020.

In September 2021, we werecompleted the acquisitions of nine pharmacies located in Chengdu through the acquisition of the outstanding equity of the entities which owned the pharmacies for an aggregate purchase price of RMB 34,635,845, or approximately US$5.31 million (“Transfer Price”). The Transfer Price will be reduced by an amount equal to any amounts paid or distributed by any of the entities to its shareholders after December 31, 2020 and increased by an amount contributed to any of the entities by its shareholders after such date.

In March 2020, the World Health Organization announced that infections caused by the coronavirus disease of 2019 (“COVID-19”) had become pandemic and national, provincial and local authorities, including those whose jurisdictions include Chengdu, where our offices, hotel and pharmacies are located, adopted various regulations and orders, including “shelter in place” rules, restrictions on travel, mandates on the number of people that may gather in one location and closing non-essential businesses. Many of these measures have been relaxed due to the decrease in the prevalence of Covid-19 in China. To date, the ongoing operations of our advertising and marketing business have not been materially adversely impacted by the measures taken to limit the spread of the disease in China. Our hotel and pharmacies, however, have experienced adverse impacts due to travel and work restrictions imposed on a “shell company” (as that termtemporary basis in Chengdu to limit the spread of COVID-19. The Company has implemented procedures to promote employee and customer safety. These measures will not significantly increase its operating costs. However, the Company cannot predict with certainty what measures may be taken by its suppliers and customers and the impact these measures may have on its financial results for the balance of 2021 and throughout 2022.

In addition to our ongoing operations, we seek to acquire interests in additional businesses through opportunities found by our management or presented by persons or firms which desire to take advantage of the perceived advantages of an Exchange Act registered corporation. We do not restrict our search to any specific business, industry, or geographical location and may participate in a business venture of virtually any kind or nature.

It is definedthe goal of our management, in Rule 12b-2 underparticular, our Chairman, Quanzhong Lin to grow our business and to modify its capital structure in order to qualify for a listing on NASDAQ or the Exchange Act) becauseNYSE-American exchange. As part of this effort, we had no or nominal assets (other than cash)will continue to seek to acquire more businesses and no or nominal operations. On December 12, 2017,to modify our capital structure as necessary to meet the requirements of the exchange to which we acquired AiXin (BVI) International Group Co., Ltd.apply for a British Virgin Islands corporation (“AiXin BVI”), for 227,352,604listing. As part of this effort. on June 8, 2020, Mr. Lin transferred 35,049,685 shares of our common stock (the “Share Exchange”). As a resultto our Company for cancellation.

27

Results of Operations

The following table sets forth the Share Exchange, AiXin BVI becameresults of our wholly-owned subsidiary, and we now own all of the outstanding shares of HK AiXin International Group Co., Limited, a Hong Kong limited company (“AiXin HK”), which in turn owns all of the outstanding shares of Chengdu AiXin Zhonghong Biological Technology Co., Ltd., a Chinese limited company (“AiXin Zhonghong”), which markets and sells innovative, premium-quality nutritional products in Chengdu, China. For information concerning the business of AiXin Zhonghong, including financial informationoperations for the yearsperiods indicated as a percentage of net revenue, certain columns may not add due to rounding:

  Three Months Ended September 30, 
  2021  2020 
  $  % of Revenue  $  % of Revenue 
Revenue $812,910   100% $728,896   100%
Operating costs and expenses  906,419   112%  409,619   56%
Income (loss) from operations  (93,509)  (12)%  319,277   44%
Non-operating income, net  21,499   3%  323,373   44%
Income tax expense  74,094   9%  2,319   -%
Net income (loss) $(146,104)  (18)% $640,331   88%

  Nine Months Ended September 30, 
  2021  2020 
  $  % of Revenue  $  % of Revenue 
Revenue $2,363,836   100% $1,774,139   100%
Operating costs and expenses  1,766,671   75%  1,122,248   63%
Income from operations  597,165   25%  651,891   37%
Non-operating income (expenses), net  17,264   1%  554,885   31%
Income tax expense  292,146   12%  2,319   -%
Net income $322,283   14% $1,204,457   68%

The following table shows our operations by business segment for the three months ended December 31, 2016September 30, 2021 and 2015, and2020:

  2021  2020 
Net revenue        
Advertising and products $509,861  $728,896 
Pharmacies  139,947   - 
Hotel  163,102   - 
Total revenues, net $812,910  $728,896 
         
Operating costs and expenses        
Advertising and products        
Cost of goods sold $38,461  $20,478 
Operating expenses  267,331   389,141 
Pharmacies        
Cost of goods sold  92,477   - 
Operating expenses  124,138   - 
Hotel        
Hotel operating costs  320,305   - 
Operating expenses  63,707   - 
Total operating costs and expenses $906,419  $409,619 
         
Income (loss) from operations        
Advertising and products $204,069  $319,277 
Pharmacies  (76,668)  - 
Hotel  (220,910)  - 
Income (loss) from operations $(93,509) $319,277 

28

The following table shows our operations by business segment for the nine months ended September 30, 2017, see2021 and 2020.

  2021  2020 
Net revenue        
Advertising and products $2,060,787  $1,774,139 
Pharmacies  139,947   - 
Hotel  163,102   - 
Total revenues, net $2,363,836  $1,774,139 
         
         
Operating costs and expenses        
Advertising and products        
Cost of goods sold $199,141  $67,379 
Operating expenses  966,903   1,054,869 
Pharmacies        
Cost of goods sold  92,477   - 
Operating expenses  124,138   - 
Hotel        
Hotel operating costs  320,305   - 
Operating expenses  63,707   - 
         
Total operating costs and expenses $1,766,671  $1,122,248 
         
Income (loss) from operations        
Advertising and products $894,743  $651,891 
Pharmacies  (76,668)  - 
Hotel  (220,910)  - 
Income (loss) from operations $597,165  $651,891 

Revenue

Revenue was $812,910 in the three months ended September 30,2021, compared to $728,896 in the same period of 2020, an increase of $84,014 or 12%. Revenue was $2,363,836 in the nine months ending September 30 2021, compared to $1,774,139 in the same period of 2020, an increase of $589,697 or 33%. The increase in revenue was mainly due to increased advertising revenue, and revenue from our Current Report on Form 8-K filed on December 14, 2017 (the “Form 8-K”).

hotel and pharmacies. The financial information contained herein reflectsresults of the operations of the hotel and pharmacies are included in our financial position andresults since the results of our operations prior to the consummationcompletion of the Share Exchangeacquisitions from July to September, 2021, respectively. For the third quarter and doesnine months ended September 30, 2021, we had advertising and products revenue of $509,861 and $2,060,787 respectively, pharmacies revenue of $139,947 and $139,947, and hotel revenue of $163,102 and $163,102. For the third quarter and nine months ended September 30, 2020, we had $728,896 and $1,774,139 in advertising and products revenue and no revenues from the hotel and pharmacies as the acquisitions were not reflectcompleted until 2021. The increase in advertising and products revenue reflects an increase in the current statusnumber of our operations. For information regarding our current business activities, please refer to the Form 8-K filed December 14, 2017.advertising customers during 2021.

29
 13

ResultsOperation Costs and Expenses

Cost of OperationsGoods Sold

We did not have any revenues during Cost of goods sold was $130,938 and $291,618 in the sixthree and threenine months ended NovemberSeptember 30, 2017.

We incurred net loss2021, respectively, compared to $20,478 and $67,379 for the comparable periods of $54,387 and $20,869 for the six months ended November 30, 2017 and 2016, respectively. We incurred net loss2020, an increase of $20,500 and $11,949$110,460 or 539% for the three months ended NovemberSeptember 30, 20172021 compared with same period of 2020, and 2016,an increase of $224,239 or 333% for the nine months ended September 30, 2021 compared with same period of 2020. The increase in our cost of goods sold is attributable to the increase in product sales due to the acquisition of the pharmacies as well as an increase in cost of goods sold from our traditional products. The cost of goods sold for our nutritional products as a percentage of was 64% and 64% in the three and nine months ended September 30, 2021, respectively, compared to 37% and 40% for the three and nine months ended September 30, 2020, respectively.

Our expenses duringThe cost of goods sold as a percentage of nutritional product sales was higher in the periods reported on herein, were primarily to maintain our corporate existence, file reportsthree and nine months ended September 30, 2021, compared with the Securitiessame period of 2020 due to increased sales volume of lower profit margin products in 2021.

Hotel Operating Costs

Hotel Operating costs were $320,305 for the three and Exchange Commission, includingnine months ended September 30, 2021, compared to $0 for the preparation comparable periods of 2020, an increase of $320,305, or 100%. The increase in hotel operating costs was primarily due to the inclusion of the hotel operating costs of Aixin Shangyan Hotel.

Operating Expenses

Operating expenses were $455,176 and audit$1,154,748 for the three and nine months ended September 30 2021, respectively, compared to $389,141 and $1,054,869 for the comparable periods of 2020, an increase of $66,305 or 17% for the three months ended September 30, 2021 compared with same period of 2020, and an increase of $99,879 or 9% for the nine months ended September 30, 2021 compared with same period of 2020. The increase in operating expenses for the three months ended September 30, 2021 was mainly due to the inclusion of the operating expenses of the hotel and pharmacies since the dates of their acquisitions and increased selling expense due to the acquisition of the hotel and pharmacies which was partly offset by decreased general and administrative expense due to the decrease in advertising revenue. The increase in operating expenses for the nine months ended September 30, 2021 was mainly due to the inclusion of the operating expenses of the hotel and pharmacies since the dates of their acquisitions and increased selling expenses and general and administrative expenses resulting from such acquisitions.

Income (loss) from Operations

Income (loss) from operations was $(93,509) and $319,277 in the three and nine months ended September 30 2021, respectively, compared to $597,165 and $651,891 in the same periods of 2020, a decrease of $412,786 or 129% for the three months ended September 30, 2021 compared with same period of 2020, and a decrease of $54,726 or 8% for the nine months ended September 30, 2021 compared with same period of 2020. The decrease in our financial statements,income from operations for the three months ended September 30, 2021 was mainly due to decreased advertising revenue and increased operating costs and expenses associatedcompared with findingthe same period of 2020. The decrease in our income from operations for the nine months ended September 30, 2021 was mainly due to the increased operating costs and expenses, partially offset by the increased revenue.

Non-operating Income

Non-operating income was $21,499 and $17,264 for the three and nine months ended September 30, 2021, respectively, compared to $323,373 and $554,885 for the comparable periods of 2020. For the three months ended September 30, 2021, we had interest income $599 and other income $22,067 and other expenses of $1,167. For the three months ended September 30, 2020, we had interest income $297,895 and other income $25,741. For the nine months ended September 30, 2021, we had interest income $3,088 and other income $22,228 and other expenses of $8,052. For the nine months ended September 30, 2020, we had interest income $529,551 and other income $25,783.

30

Income tax expense

Income tax expense were $74,094 and $292,146 for the three and nine months ended September 30, 2021, compared to $2,319 and $2,319 in the same periods of 2020, an appropriateincrease of $289,827 or 12,498% for the nine months ending September 30, 2021; an increase of $71,775 or 3,095% for the three months ending September 30, 2021.

Net Income (Loss)

Our net income (loss) for the three and nine months ended September 30, 2021 was $(146,104) and $322,283 respectively, compared to net income $640,331 and $1,204,457 in the same periods of 2020, a decrease in net income of $786,435 or 123%for the three months ended September 30, 2021 compared with same period of 2020, and a decrease of $882,174 or 73% for the nine months ended September 30, 2021 compared with same period of 2020. The decrease in net income in the nine and three months ended September 30, 2021 was mainly due to an increase in our income tax expense primarily in the nine months ending September 30, 2021, and a decrease in interest income and increased operating expenses due to the acquisition candidate. Our expenses have been paid from capital contributions and advances from affiliates of the Company.hotel and pharmacies.

Liquidity and Capital Resources

During 2020 and 2021, we depended upon advances from our major shareholder and capital raised in private placements to support our operations. During the nine months ended of September 30, 2021, we generated $546,069 from operations. As of NovemberSeptember 30, 2017,2021, cash and cash equivalents were $3,297,835, compared to $7,676,689 as of December 31, 2020. At September 30, 2021, we had $0working capital of $820,305 compared to $6,753,486 at December 31, 2020. The reduction in cash. We have financed our operationscash from December 31, 2020 to September 30, 2021, was the result of the payments made to acquire Aixin Shangyan Hotel and Aixintang Pharmacies.

The following is a summary of cash provided by or used in each of the indicated types of activities during the nine months ended September 30, 2021 and 2020, respectively.

  

September 30, 2021

  

September 30, 2020

 
Net cash provided by operating activities $546,069  $1,456,421 
Net cash (used in) provided by investing activities $(4,410,524) $4,033,470 
Net cash (used in) provided by financing activities $(592,814) $2,227,904 

Net cash provided by operating activities

For the nine months ended September 30, 2021, net cash provided by operating activities was $546,069. This was primarily due to our net income of $322,283, adjusted by non-cash related expenses including depreciation of $21,910, provision for bad debt of $17,883 and stock-based compensation of $278,655, and then decreased by changes in working capital of $94,662. The cash outflow from changes in working capital mainly resulted from inventory purchases of $18,728, payments of advances to suppliers of $116,795, and payments of accrued liabilities $41,986, partly offset by cash inflow from other receivables and prepaid expenses, unearned revenue and an increase in taxes payable outstanding of $46,672.

For the nine months ended September 30, 2020, net cash provided by operating activities was $1,456,421. This was primarily due to our net income of $1,204,457, adjusted by non-cash related expenses including depreciation of $34,572, provision for bad debt of $13,451, and stock-based compensation of $278,655, and then decreased by changes in working capital of $74,714. The changes in working capital mainly resulted from a decrease in accrued liabilities and other payables of $99,549, an increase in inventory of $31,830, and a decrease in taxes payable of $24,966, partly offset by a decrease in advance to suppliers of $63,235 and a decrease in other receivables and prepaid expenses of $17,327.

31

Net cash (used in) provided by investing activities

For the nine months ended September 30, 2021, net cash used in investing activities was $4,410,524, mainly for the acquisition of a hotel and pharmacies from our major shareholder.

For the nine months ended September 30, 2020, net cash provided by investing activities was $4,033,470, which was mainly due to the return of a prepayment for the acquisitions of $4,035,615, partly offset by purchases of property and equipment of $2,145.

Net cash (used in) provided by financing activities

For the nine months ended September 30, 2021, net cash used in financing activities were changes in advances from related parties. At Novemberparties of $592,814.

For the nine months ended September 30, 2017, the balance due2020, net cash provided by financing activities was an advance from our major shareholder of $2,227,904.

Impact of Inflation

Our results of operations may be affected by inflation, particularly rising prices for products and other operating costs if we cannot pass such increases along to our shareholders and officer was $248,265, which was payable on demand without interest. Since we have no cash, we cannot satisfy our cash requirements and need to obtain financing. We cannot assure investors that adequate financing will be available. In the absence of such financing, we may be unable to proceed with our plan of operations.

At November 30, 2017 and May 31, 2017, the amounts due to related parties was $248,265 and $166,677, respectively.

Contractual Obligations

At November 30, 2017, our obligations were: accounts payable, loan due to stockholders and officer, and advance from a third party for paying the company’s operating expenses of $259,292.

Off-Balance Sheet Arrangements

We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have a material current or future effect upon our financial condition or results of operations.

Critical Accounting Policies and Estimates

Going Concern

As showncustomers in the accompanying financial statements, at November 30, 2017,form of higher prices for our products and services. Generally, our inventory turns multiple times per year and we had no cash, a deficit working capital of $259,292 and stockholders’ deficit of $259,292, and a net loss of $54,387 for the six months ended November 30, 2017, which raise substantial doubt about our ability to continue as a going concern.

The report of our independent registered public accountants on our financial statements as of and for the year ended May 31, 2017 states that these conditions, among others, raise substantial doubt about our ability to continue as a going concern. Our financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amount and classification of liabilities that might be necessary in the event we cannot continue as a going concern.

Our future success is dependent upon, among other things, our ability to raise additional capital or to secure a future business combination. There is no guaranteeanticipate that we will be able to raise enough capitalincrease prices on products to reflect increases in the cost of inventory.

Contractual Obligations

We have no long-term fixed contractual obligations or generatecommitments.

Off-Balance Sheet Arrangements

We have not entered into any financial guarantees or other commitments to guarantee the obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as shareholder’s equity or that are not reflected in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any uncombined entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.

Contingencies

The Company’s operations are conducted in the PRC and are subject to specific considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments in China and foreign currency exchange. The Company’s results may be adversely affected by changes in PRC government policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad and rates and methods of taxation, among other things.

The Company’s sales, purchases and expense transactions in China are denominated in RMB and all of the Company’s assets and liabilities in China are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current PRC law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation in order to affect the remittance.

32

Significant Accounting Policies

Our management’s discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which were prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported net sales and expenses during the reporting periods. On an ongoing basis, we evaluate our estimates and assumptions. We base our estimates on historical experience and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

While our significant accounting policies are more fully described in Note 2 to our consolidated financial statements, we believe the following accounting policies are the most critical to assist you in fully understanding and evaluating this management discussion and analysis.

Basis of Presentation

The accompanying financial statements are prepared in conformity with U.S. Generally Accepted Accounting Principles (“US GAAP”). The functional currency of Aixin is Chinese Renminbi (‘‘RMB’’). The accompanying financial statements are translated from RMB and presented in U.S. dollars (“USD”).

Use of Estimates

In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.

Significant estimates, required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.

Accounts Receivable

The Company maintains an allowance for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to sustain our operations. Our management believes it can raiseevaluate the appropriate funds needed to support its business planadequacy of these reserves. During the nine months ended in September 30, 2021 and acquire an operating company with positive cash flow.2020, bad debt expense was $17,883 and $13,451, respectively. During the three months ended September 30, 2021 and 2020, bad debt expense (reversal) was $17,883 and $(75), respectively. As of September 30, 2021 and December 31, 2020, the bad debt allowance was $292,742 and $148,520, respectively.

Recent Accounting Pronouncements

Revenue Recognition

In August 2016, the FASB issued

ASU No. 2016-15, Classification2014-09, Revenue from Contracts with Customers (“Topic 606”), became effective for the Company on January 1, 2018. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of Certain Cash ReceiptsTopic 606. As revenues are and Cash Payments. ASU 2016-15 clarifieshave been primarily from the presentationdelivery of products and classificationthe performance of certain cash receiptsservices, and cash paymentsthe Company has no significant post-delivery obligations, this did not result in a material recognition of revenue on the Company’s accompanying consolidated financial statements for the cumulative impact of applying this new standard. The Company made no adjustments to its previously-reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under Topic 605, Revenue Recognition.

Revenue from sale of goods under Topic 606 is recognized in a manner that reasonably reflects the delivery of the Company’s products and services to customers in return for expected consideration and includes the following elements:

executed contract(s) with customers that the Company believes is legally enforceable;

identification of performance obligation in the respective contract;

determination of the transaction price for each performance obligation in the respective contract;

allocation of the transaction price to each performance obligation; and

recognition of revenue only when the Company satisfies each performance obligation.

33

The Company’s revenue recognition policies for its various operating segments are as follows:

Advertising and Products

Advertising Revenue

Commencing in the statementthird quarter of cash flows.2019, AiXin Zhonghong began to provide advertising services to its clients. Advertising contracts are signed to establish the price and advertising services to be provided. Pursuant to the advertising contracts, the Company provides advertising and marketing services to its clients through exhibition events, conferences, and person-to-person marketing. The Company performs a credit assessment of the customer to assess the collectability of the contract price prior to entering into contracts.

Most of the advertisement contracts designated that the Company perform such advertising services for its clients through exhibition events, conferences, and person-to-person marketing during the contracted period, regardless of the number of such events. As such, the Company determined that the performance obligation is satisfied over time during the contracted period and revenue is recognized accordingly. Such advertising revenue amounted to $445,215 and $673,978 for the three months ended September 30, 2021 and 2020, respectively. Such advertising revenue amounted to $1,742,896 and $1,597,330 for the nine months ended September 30, 2021 and 2020, respectively.

A smaller proportion of the Company’s advertising revenue is generated from services to its clients through exhibition events, conferences, and person-to-person marketing, and charges based on the number of promotional products sold. Such advertising revenue amounted to $0 for the three months ended September 30, 2021 and 2020. Such advertising revenue amounted to $0 and $6,476 for the nine months ended September 30, 2021 and 2020, respectively.

All of the advertising revenue is subject to the PRC VAT of 6%. This ASUVAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China.

Products Revenue

The Company’s revenue from sale of products is effective for public business entities for fiscal years,recognized when goods are delivered to the customer and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted.no other obligation exists. The Company does not anticipateprovide unconditional return or other concessions to the adoptioncustomer. The Company’s sales policy allows for the return of this ASU willunopened products for cash after deducting certain service and transaction fees. As an alternative to the product return option, the customers have options of asking for an exchange for products with the same value.

Sales revenue of AiXin Zhonghong represents the invoiced value of goods, net of value-added taxes (“VAT”). All of the Company’s products sold in China are subject to the PRC VAT of 17% of the gross sales price prior to May 1, 2018, 16% since May 1, 2018 and 13% since April 1, 2019. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China. The Company records VAT payable and VAT receivable net of payments in the financial statements. The VAT tax return is filed offsetting the payables against the receivables. Sales and purchases are recorded net of VAT collected and paid as the Company acts as an agent for the government.

Hotel

Hotel revenues are primarily derived from the rental of rooms, food and beverage sales and other ancillary goods and services, including but not limited to souvenir, parking and conference reservation. Each of these products and services represents a significant impactdistinct performance obligation and, in exchange for these services, the Company receives fixed amounts based on published rates or negotiated contracts. Payment is due in full at the time when the services are rendered or the goods are provided. Room rental revenue is recognized on a daily basis when rooms are occupied. Food and beverage revenue and other goods and services revenue are recognized when they have been delivered or rendered to the guests as the respective performance obligations are satisfied. All of the hotel’s goods sold in China are subject to the PRC VAT of 6%. This VAT may be offset by VAT paid by the Company on raw materials and other materials purchased in China.

Pharmacies

The Company’s retail drugstores (Aixintang Pharmacies) recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its financial statementsown arrangement with the customer and is a performance obligation. Aixintang Pharmacies generally receives payments from customers as it satisfies its performance obligations. The Company records a receivable when it has an unconditional right to receive payment and only the passage of time is required before payment is due. Sales revenue represents the invoiced value of goods, net of VAT. All of Aixintang Pharmacies’ products sold in China are subject to the PRC VAT of 0% as it qualifies for small businesses.

34
 14

In November 2016, the FASB issued ASU No. 2016-18, Statement

Foreign Currency Translation and Comprehensive Income (Loss)

The functional currency of Cash Flows (Topic 230): Restricted Cash. The guidance requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The standard is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The standard should be applied using a retrospective transition method to each period presented. The Company does not anticipate the adoption of this ASU will have a significant impact on its financial statements.

In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. The standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted. The standard should be applied prospectively on or after the effective date. The Company does not anticipate the adoption of this ASU will have a significant impact on its financial statements.

The Company has reviewed all other recently issued but not yet effective accounting pronouncements and have determined that these new accounting pronouncements are either not applicable or would not have a material impact on its results of operations or financial position.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

As a smaller reporting company, the Company is not requiredRMB. For financial reporting purposes, RMB is translated into USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet dates. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period.

Translation adjustments arising from the use of different exchange rates from period to provideperiod are included as a component of stockholders’ equity as “Accumulated other comprehensive income”. Gains and losses resulting from foreign currency transactions are included in income. There was no significant fluctuation in the information requiredexchange rate for the conversion of RMB to USD after the balance sheet date.

We use FASB ASC Topic 220, “Comprehensive Income”. Comprehensive income (loss) is comprised of net income (loss) and all changes to the statements of stockholders’ equity, except those due to investments by this Item.stockholders, changes in paid-in capital and distributions to stockholders. Comprehensive loss for nine and three months ended September 30, 2021 and 2020 consisted of net loss and foreign currency translation adjustments.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

We maintainManagement of AiXin Life International, Inc. is responsible for maintaining disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in ourthe reports that we file or submit under the Securities Exchange Act reportsof 1934 (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms,forms. In addition, the disclosure controls and procedures must ensure that such information is accumulated and communicated to our management, including theour Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Management necessarily applies its judgment in assessing the costsfinancial and benefitsother required disclosures.

At September 30, 2021, an evaluation of such controls and procedures, which, by their nature, can provide only reasonable assurance regarding management’s control objectives.

During the quarter ended February 28, 2017, there was a change in control of our Company as a result of the sale of more than 95% of our shares currently outstanding. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e)Rules 13(a)-15(e) and 15(d)-15(e) of the Exchange Act was carried out under the Exchange Act) assupervision and with the participation of the end of the period covered by this report. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that the design and operationOfficer. Based on their evaluation of our disclosure controls and procedures, were not effective as ofthey concluded that at June 30, 2021, such date to provide assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and that such information is accumulated and communicated to management as appropriate to allow timely decisions regarding disclosure. The principal deficiency in ourdisclosure controls and procedures derives fromwere not effective. This was due to our limited resources, including the lackabsence of familiaritya financial staff with accounting and financial expertise and deficiencies in the design or operation of currentour internal control over financial reporting that adversely affected our disclosure controls and that may be considered to be “material weaknesses.”

We plan to designate individuals responsible for identifying reportable developments and to implement procedures designed to remediate the material weakness by focusing additional attention and resources in our internal accounting functions. However, the material weakness will not be considered remediated until the applicable remedial controls operate for a sufficient period of time and management with U. S. Securities Laws and Regulations and applicable accounting standards.has concluded, through testing, that these controls are operating effectively.

15

Changes in Internal Control over Financial Reporting

There have not been any changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter which is the subject of this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

35

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

There is no pending litigation to which the Company iswe are presently a party or to which the Company’sour property is subject and management is not aware of any litigationfacts which may ariseare likely to result in litigation in the future.

ItemItem 1A. Risk Factors

Reference is made to the risks and uncertainties disclosed in Item 1A (“Risk Factors”Factors) of our Current Report on2020 Form 8-K reporting the acquisition of AiXin (BVI) International Group Co., Ltd. filed on December 14, 2017 (the “Form 8-K”),10-K, which are incorporated by reference into this report. Prospective investors are encouraged to consider the risks described in the 20172020 Form 8-K,10-K, Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in the Form 8-Kthis report and other information publicly disclosed or contained in documents we file with the Securities and Exchange Commission before purchasing our securities.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the quarter ended NovemberSeptember 30, 2017,2021, we did not have any sales of equity securities in transactions that were not registered under the Securities Act of 1933, as amended, that have not been previously reported in a Form 8-K.report filed pursuant to the Exchange Act.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

N/A.

Item 5. Other Information

On December 12, 2017, we entered into and closed a share exchange agreement, or the Share Exchange Agreement, with AiXin (BVI) International Group Co., Ltd. a British Virgin Islands corporation (“AiXin BVI”), and Quanzhong Lin, the sole stockholder of AiXin BVI (the “AiXin BVI Stockholder”), pursuant to which we acquired 100% of the outstanding capital stock of AiXin BVI for 227,352,604 shares of our common stock (the “Share Exchange” or the “AiXin Acquisition”). The foregoing description of the terms of the Share Exchange Agreement is qualified in its entirety by reference to the provisions of the Share Exchange Agreement filed as Exhibit 2.1 to the Form 8-K. After giving effect to the Share Exchange, we had outstanding 317,988,089 shares of common stock.None

As a result of the Share Exchange, AiXin BVI became our wholly-owned subsidiary, and we now own all of the outstanding shares of HK AiXin International Group Co., Limited, a Hong Kong limited company (“AiXin HK”), which in turn owns all of the outstanding shares of Chengdu AiXin Zhonghong Biological Technology Co., Ltd., a Chinese limited company (“AiXin Zhonghong”), which markets and sells innovative, premium-quality nutritional products in Chengdu, China. For additional information concerning the business of AiXin Zhonghong, see the Form 8-K.

16

Prior to the AiXin Acquisition, Quanzhong Lin, our President and Chief Executive Officer, owned all of the outstanding shares of AiXin BVI and 29,521,410 shares of our common stock, approximately 65% of the outstanding shares of Mercari Communications Group, Ltd. As a result of the Share Exchange, Mr. Lin now owns 256,874,014 shares of our common stock, 80.78% of our outstanding shares, after giving effect to certain other issuances described in the Form 8-K under the caption “Market for Registrant’s Common Equity and Related Stockholder Matters.”

For accounting purposes, the acquisition has been accounted for as a reverse acquisition and has been treated as a recapitalization of Mercari Communications Group, Ltd. effected by a share exchange, with AiXin BVI as the accounting acquirer. Since neither AiXin BVI nor AiXin HK had operations prior to December 12, 2017, the historical financial statements of AiXin Zhonghong are now the historical financial statements of the registrant, Mercari Communications Group, Ltd., and have been included in Item 9.01(a) of the Form 8-K. The assets and liabilities of AiXin Zhonghong have been brought forward at their book value and no goodwill has been recognized.

We have filed an amendment to our Articles of Incorporation changing our corporate name to AiXin Life International, Inc. (the “Name Change Amendment”), which is expected to become effective on or about February 1, 2018, subject to approval by the Financial Regulatory Authority, or FINRA. The Name Change Amendment was approved by written consent of shareholders owning a majority of our outstanding shares and we have filed with the SEC and mailed to our shareholders an Information Statement with respect to the Name Change Amendment.

Item 6. Exhibits

Exhibit
Number

No.

Description of Exhibit
2.1Share Exchange Agreement, dated as of December 12, 2017, among the Company, AiXin BVI, AiXin HK, AiXin ZhonghongAiXinZhonghong and the stockholders of Aixin ZhonghongAixinZhonghong (incorporated herein by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on December 14, 2017).
3.1Articles of Incorporation (incorporated by reference to the Company’s Annual Report on Form 10-KSB for the fiscal year ended May 31, 2006 as filed with the SEC on March 7, 2007).
3.2Articles of Amendment to Articles of Incorporation (incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on June 3, 2008).
3.3Articles of Amendment to Articles of Incorporation changing(incorporated by reference to Exhibit 3.3 the name ofCompany’s Quarterly Report on Form 10-Q for the Company to AiXin Life International, Inc.quarterly period ended November 30, 2017 as filed with the SEC on January 16, 2019).
3.4Bylaws of the Registrant (incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on June 3, 2008).
10.1Stock PurchaseEquity Transfer Agreement dated December 20, 2016, between Algodon and China Concentric, as amended (incorporated hereinwith Respect to Shangyan Hotel Company (Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on December 14, 2017)dated May 25, 2021).
10.2Stock PurchaseEquity Transfer Agreement dated December 21, 2016, between China Concentricwith respect to Chengdu Aixin Pharmacy Co., Ltd. and Quanzhong Lin (incorporated hereinaffiliated entities (Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on December 14, 2017)dated June 2, 2021).
31.1Certification of the PrincipalChief Executive Officer Pursuantpursuant to Section 302Rule 13a-14 or Rule 15d-14 of the Sarbanes-OxleySecurities Exchange Act of 2002.1934.
31.2Certification of the PrincipalChief Financial Officer Pursuantpursuant to Section 302Rule 13a-14 or Rule 15d-14 of the Sarbanes-OxleySecurities Exchange Act of 2002.1934.
32.1Certification of the PrincipalChief Executive Officer Pursuantpursuant to Section 906 of the Sarbanes-Oxley Act of 2002.2002 (18 U.S.C. Section 1350).
32.2Certification of the PrincipalChief Financial Officer Pursuantpursuant to Section 906 of the Sarbanes-Oxley Act of 2002.2002 (18 U.S.C. Section 1350).
101.INSiXBRL Instance Document
101.SCHiXBRL Taxonomy Extension Schema
101.CALiXBRL Taxonomy Extension Calculation
101.DEFiXBRL Taxonomy Extension Definition
101.LABiXBRL Taxonomy Extension Label
101.PREiXBRL Taxonomy Extension Presentation

101.INS XBRL Instance Document

101.SCH XBRL Schema Document

101.CAL XBRL Calculation Linkbase Document

101.DEF XBRL Definition Linkbase Document

101.LAB XBRL Label Linkbase Document

101.PRE XBRL Presentation Linkbase Document

36
 17

SIGNATURES

SIGNATURES

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MERCARI COMMUNICATIONS GROUP, LTD.AIXIN LIFE INTERNATIONAL, INC.
Dated: January 16, 2018November 22, 2021By:/s/ Quanzhong Lin
Quanzhong Lin
President and Chief Executive Officer
(Principal Executive Officer)

1837